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ABSTRACT 
Mesencephalic astrocyte-derived neurotrophic factor (MANF) and cerebral dopamine 
neurotrophic factor (CDNF) proteins form a family of neurotrophic factors. Neurotrophic 
factors have been intensively studied as a putative therapeutic approach to treat neuronal 
injuries and neurodegenerative diseases. Mammalian MANF and CDNF have been shown 
to have protective and restorative effects on the nigrostriatal dopaminergic system. In 
addition, several studies have reported a role for MANF in the endoplasmic reticulum 
(ER) stress response. A recently established MANF knockout mouse model revealed that 
MANF functions in the pancreatic insulin-producing b-cells and might be involved in the 
pathogenesis of diabetes mellitus. Beyond their neurotrophic properties, MANF and 
CDNF appear to play a more general role in the maintenance of cellular homeostasis. 
In this study, Drosophila melanogaster was used as a model organism to explore the 
function and interaction of the MANF/CDNF protein family in vivo. The sole member of 
the MANF/CDNF family in Drosophila,  DmManf,  was  discovered  to  be  crucial  for  fly  
development. The human orthologues, HsMANF and HsCDNF, were found to be able to 
substitute the endogenous DmManf. Likewise, DmManf had the cytoprotective properties 
of mammalian MANF in cultured murine neurons. These results support that the findings 
from the Drosophila model can be adapted for research in mammalian systems. 
MANF/CDNF proteins consist of amino (N) - and carboxy (C) -terminal domains. In 
this work, several functional features identified in mammalian MANF structure were 
explored in the Drosophila model. Separate N- or C-terminal domain constructs, even 
when co-expressed together, failed to complement for the loss of endogenous DmManf. 
The  ER  retention  of  DmManf,  mediated  by  the  C-terminal  signal  sequence,  and  the  
positive charge of the N-terminal surface amino acid residues were found to be important 
for appropriate DmManf function. Furthermore, entering the secretory pathway via ER 
was essential for the stability of DmManf protein. 
A CXXC motif characteristic for oxidoreductases is located in the C-terminal domain 
of MANF. In this study, effects of a point mutation (C129S) in CXXC motif of DmManf 
were analysed in vivo. Intact CXXC motif was discovered to be vital for DmManf 
function. Furthermore, the expression of DmManf-C129S in wild type background was 
harmful for fly viability suggesting that this specific mutation represents either a dominant 
negative or a gain-of-function allele of DmManf. 
Utilising the unique potential of Drosophila model for in vivo screening, interactions 
of DmManf were studied in this work. Consistent with a previous in vitro study, a genetic 
interaction was found between DmManf and the fly homologue of the major ER chaperone 
GRP78. Moreover, DmManf interacted  with  other  genes  that  encode  components  of  ER  
function and the unfolded protein response. Finally, novel interactions with DmManf and 
genes involved in the ubiquinone synthesis pathway and mitochondria were discovered. 
Taken together, this study demonstrates the functional conservation of mammalian and 
fly proteins and provides meaningful information on structural and functional features of 
the MANF/CDNF protein family in vivo. The genetic interaction studies confirmed and 
expanded the previous knowledge on the ER-associated functions of MANF. Furthermore, 
novel interactions with mitochondria-related genes and DmManf were discovered. 
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1 REVIEW OF THE LITERATURE 
1.1 Overview of neurotrophic factors 
Neurotrophic factors, a subclass of growth factors, are small, secreted proteins which 
signal through their specific receptors. They regulate different neuronal processes, 
including migration, differentiation, synaptic plasticity, survival and regeneration. 
Additionally, several other growth factors have been found to have neurotrophic function 
and, conversely, functions in non-neuronal tissues have been revealed for neurotrophic 
factors. Due to their cell survival promoting activity, neurotrophic factors are considered 
as promising agents for treatments of neuronal degeneration (reviewed in Ramaswamy 
and Kordower 2009). 
Currently, neurotrophic factors are classified into four main families according to 
homology on the amino acid sequence level and structural similarity. Neurotrophin family 
(reviewed in Huang and Reichardt 2001) includes the first neurotrophic factor found, 
nerve growth factor (NGF) (Levi-Montalcini and Hamburger 1951; Levi-Montalcini 
1987). Neurotrophins signal via two receptors, tropomyosin-related kinase (TRK) or p75 
neurotrophin receptor. The other families are glial-derived neurotrophic factor (GDNF) 
family ligands (GFLs) (reviewed in Airaksinen and Saarma 2002), neurokine family 
(reviewed in Stolp 2013) and MANF/CDNF (mesencephalic astrocyte-derived 
neurotrophic factor/cerebral dopamine neurotrophic factor) family (reviewed in Lindholm 
and Saarma, 2010). GFLs signal through RET (ret proto-oncogene) receptor tyrosine 
kinase that is activated by co-receptor GFRa (GDNF  family  receptor  alpha)  and  the  
corresponding GFL complex. Additionally, GDNF can signal through NCAM (neural cell 
adhesion molecule) receptor that binds both GFRa and GDNF (Paratcha et al. 2003) and 
via Syndecan-3 (Bespalov et al. 2011). 
For a long time, non-cell-autonomous neurotrophic support was thought to exist only 
in vertebrates and the development of invertebrate nervous system was considered to be 
cell-autonomously programmed. However, homologues for neurotrophic factors – 
although partial – and their receptors have been discovered by analyzing the invertebrate 
genomes and protein structures (Bothwell 2006). In Drosophila, Neurotrophin-1 and -2, 
members of Spätzle family, show partial structural homology to mammalian neurotrophins 
and support the survival of peripheral neurons (Zhu et al. 2008). However, no homologues 
for the TRK receptors have been found in Drosophila. Homologues to GDNF receptor 
RET (Sugaya et al. 1994) and Gfr-like (Gfrl) co-receptor (Hätinen et al. 2007) have been 
found in Drosophila while GFL homologues have not been identified (Airaksinen et al. 
2006). GFLs have been suggested to evolve from existing TGF-b (transforming growth 
factor beta) -like proteins (Hätinen et al. 2007). Drosophila Gfrl, expressed in distinct cells 
from Drosophila Ret, failed to phosphorylate both Drosophila and mammalian RET 
(Kallijärvi et al. 2012). However, Gfrl genetically interacted with Drosophila NCAM, the 
other known binding partner of mammalian GFRa. 
REVIEW OF THE LITERATURE  
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In contrast to other neurotrophic factor families, the most recently found 
MANF/CDNF family has a functionally conserved homologue in invertebrates (I, II). 
1.2  The MANF/CDNF protein family 
1.2.1 Discovery of MANF and CDNF 
MANF  was  originally  discovered  from  screening  a  cultured  media  of  rat  ventral  
mesencephalic cell line 1 to identify proteins that support embryonic midbrain 
dopaminergic neurons (Petrova et al. 2003). In vertebrates, a homologous protein, CDNF, 
was identified (Lindholm et al. 2007). Human MANF and CDNF share 53% identical 
amino acid sequences (Lindholm et al. 2007). MANF and CDNF form a sole family of 
neurotrophic factors that includes invertebrate homologues with conserved amino acid 
sequence (Petrova et al. 2003; Lindholm et al. 2007). In invertebrates only one homologue 
exists and is more similar to mammalian MANF than CDNF (Lindholm et al. 2007). The 
Drosophila homologue,  DmManf,  shows  53%  and  49%  identity  to  human  MANF  
(HsMANF) and CDNF (HsCDNF), respectively (Lindholm et al.  2007).  The amino acid 
sequences of HsMANF, HsCDNF and DmManf are presented in Figure 1. 
 
Figure 1. Amino acid sequence alignment of human MANF (HsMANF), human CDNF (HsCDNF) and 
Drosophila Manf (DmManf). The numbering above amino acid sequences corresponds to DmManf without 
signal sequence. The signal sequence, N-terminal domain and C-terminal domain are coloured in orange, 
blue and green, respectively. The conserved eight cysteine residues are indicated by asterisks (*). Alpha-
helixes (a) are marked under amino acid sequence and coloured according to ribbon diagram presented in 
Figure 2. Purple square indicates C-terminal CXXC motif, red square C-terminal endoplasmic reticulum 
retention signal. Amino acid residues coloured in white and yellow indicate the point mutations in transgenic 
constructs DmManf-NMG1 and DmManf-NMG2, respectively (see Figure 9 and Chapter 4.2.1 in Results 
and discussion). Reprinted from II. 
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Human  MANF  has  also  been  referred  as  ARP  (arginine-rich  protein;  Shridhar  et  al.  
1996b) or ARMET (arginine-rich, mutated in early stages of tumor). In line, CDNF has 
been referred as ARMET-L1 (ARMET-like 1). This originates from studies on human 
ARP, which has an alternative ORF (open reading frame) and was predicted to hold an 
arginine-rich amino (N) -terminal region. However, ARP with the arginine-rich tract has 
never been detected to be expressed at protein level and it seems that this ORF is not 
synthesized in vivo (Petrova et al. 2003). Mutations in the arginine-rich part of ARP were 
linked to various forms of cancer (Shridhar et al. 1996a; Shridhar et al. 1996b; Shridhar et 
al. 1997) but further studies revealed that the identified mutations appear as normal 
polymorphisms (Evron et al. 1997; Tanaka et al. 2000; Piepoli et al. 2006). Drosophila 
Manf was originally identified as D-ARP (later also known as ARP-like) from yeast-based 
signal sequence trap screen to isolate genes encoding secreted and membrane proteins 
(Goo et al. 1999). A putative signal sequence typical for secreted proteins was identified in 
the  N-terminus  of  D-ARP  lacking  the  arginine  rich  domain  of  human  ARP  (Goo  et  al.  
1999). 
1.2.2 Molecular characteristics of mammalian MANF and CDNF 
Both MANF and CDNF are approximately 18 kDa, highly soluble proteins found as 
monomers in neutral pH (Lindholm et al. 2007; Mizobuchi et al. 2007). They are secreted 
from transiently transfected cells (Lindholm et al. 2007; Lindholm et al. 2008). 
Endogenous MANF has also been shown to be secreted in vitro (Apostolou et al. 2008). 
However, the majority of MANF protein seems to remain intracellular (Glembotski et al. 
2012) and MANF is partially retained in endoplamic reticulum (ER) (Mizobuchi et al. 
2007; Apostolou et al. 2008). Mouse MANF and CDNF were found to be relatively 
widely expressed (Lindholm et al. 2007; Mizobuchi et al. 2007; Lindholm et al. 2008). 
Particularly high MANF levels have been detected in the secretory cells and tissues. 
The  premature  human MANF consists  of  179  amino acids.  The  first  21  amino  acids  
represent a signal sequence peptide that directs the translation of the polypeptide to the 
secretory pathway via ER (Petrova et al. 2003). Originally, MANF was reported to be 
glycosylated (Petrova et al. 2003) but in later studies, post-translational modifications 
were not detected in secreted MANF in vitro (Lindholm et al. 2008). Human and mouse 
MANF do not contain putative glycosylation sites (Lindholm and Saarma 2010). 
Human CDNF includes a signal sequence of 26 amino acids and the mature protein 
consists of 161 amino acids (Lindholm et al. 2007). Mouse CDNF lacks putative 
glycosylation sites but in human CDNF, one putative N-glycosylation and one O-
glycosylation sites are found (Lindholm et al. 2007; Sun et al. 2011). Both glycosylated 
(Apostolou et al. 2008) and unglycosylated (Lindholm et al. 2007) forms have been shown 
to be secreted from CDNF overexpressing cells. Glycosylation of CDNF is not necessary 
for its secretion or biological activity (Lindholm et al. 2007; Sun et al. 2011). 
REVIEW OF THE LITERATURE  
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1.2.3 Structure of MANF and CDNF 
Disulphide bridges are formed between cysteine residues to stabilize the structure of 
proteins (reviewed in Oka and Bulleid 2013). One notable feature of the MANF/CDNF 
family is the strict conservation of the spacing between the eight cysteine residues found 
also in Caenorhabditis elegans (C. elegans) and Drosophila Manf, the invertebrate family 
members (Petrova et al. 2003). Thus, the three-dimensional structure of MANF/CDNF has 
been predicted to be conserved during evolution. All eight cysteine residues of MANF 
form intramolecular disulphide bridges (Parkash et al. 2009; Hellman et al. 2011). The 
structural studies by crystallography and NMR (nuclear magnetic resonance) spectroscopy 
showed that MANF and CDNF have two domains, N- and carboxy (C) -terminal, 
connected with a flexible linker region (Parkash et al. 2009; Hellman et al. 2010; Hoseki 
et al. 2010; Hellman et al. 2011; Latgé et al. 2013). A ribbon diagram of human MANF is 
presented in Figure 2. 
 
Figure 2: Ribbon diagram of human MANF structure. Alpha-helixes (a) are numbered. The C-terminal 
CXXC motif and non-canonical ER retention signal RTDL are indicated. Reprinted from II. 
1.2.3.1 The saposin-like N-terminal domain of MANF and CDNF 
The globular N-terminal domain of MANF and CDNF consists of five alpha-helixes and 
one  310 helix (Parkash et al. 2009). The N-terminal domain is stabilized by three 
disulphide bridges formed by cysteine pairs C6–C93, C9–C82 and C40–C51 (numbering 
according to human MANF without signal sequence, Figures 1 and 2) (Parkash et al. 
2009; Hoseki et al. 2010; Hellman et al. 2010). A structural similarity was found to 
SAPLIP (saposin-like protein) domain and the closest similarity was found to two 
membrane-lytic proteins of SAPLIP family, granulysin and NK-lysin (Parkash et al. 2009; 
Hellman et al. 2011). SAPLIPs form a functionally diverse protein family interacting with 
lipids and membranes (reviewed in Bruhn 2005). According to the structural similarity to 
SAPLIPs,  the  positively  charged  surface  amino  acid  residues  of  MANF  and  CDNF  are  
predicted to interact with negatively charged lipids (Parkash et al. 2009). This putative 
lipid interaction has not yet been demonstrated. 
REVIEW OF THE LITERATURE 
 
 
 
 
13
1.2.3.2 C-terminal domain of MANF is structurally similar to SAP-domain of Ku70 
There are two cysteine residues in C-terminal domain of MANF (C-MANF), C127 and 
C130, which form a disulphide bond (Parkash et al. 2009; Hoseki et al. 2010; Hellman et 
al. 2011). This CXXC motif is characteristic for the superfamily of thiol-disulphide 
oxidoreductases (reviewed in Wouters et al. 2010). The CXXC motif of MANF does not 
have oxidoreductase activity or bind metal ions (Mizobuchi et al. 2007; Hartley et al. 
2013).  Another  feature  of  the  C-terminal  domain  of  MANF/CDNF  is  the  RTDL/KTEL  
amino acid sequence that resembles the canonical ER retention signal (see Chapter 1.3.4). 
Although MANF and CDNF have been predicted to possess high structural similarity 
(Parkash et al. 2009), the structure of C-terminal domain of CDNF has not yet been 
reported. 
The NMR studies revealed that the human C-MANF is structurally similar to the SAP 
(SAF-A/B, Acinus and PIAS) protein superfamily (Hellman et al. 2011). The highest 
homology was found to the SAP domain of Ku70 [Ku autoantigen p70 subunit, also 
known as XRCC6 (X-ray repair complementing defective repair in Chinese hamster cells 
6)]. Ku70, via the SAP-domain, binds and inactivates pro-apoptotic BAX [BCL-2 (B cell 
lymphoma 2) associated X protein] in cytoplasm (Sawada et al. 2003; Cohen et al. 2004). 
When dissociated from Ku70, BAX activates the mitochondrial cell death pathway and is 
the main pro-apoptotic effector in neurons (Sawada et al. 2003; Amsel et al. 2008, see also 
Chapter 1.3.3). Intracellular full-length MANF, injected either as an encoding plasmid into 
the  nucleus  or  as  a  purified  recombinant  protein  into  the  cytoplasm,  was  found  to  be  
cytoprotective towards etoposide-induced BAX-mediated cell death in vitro (Hellman et  
al. 2011). C-MANF alone also blocked etoposide-induced cell death (Hellman et al. 2011). 
When added to the medium as a recombinant protein, MANF did not protect cultured 
neurons from cell  death and did not either bind or enter into the neurons (Hellman et  al.  
2011). 
1.2.3.3 Disruption of alpha-helixes alters intracellular trafficking and secretion of 
CDNF 
The relationship of alpha-helical structure of CDNF and function was assessed by proline 
insertions in individual alpha-helixes and by alanine substitutions in an in vitro study (Sun 
et al. 2011). While insertion of a proline residue might distract the protein folding, 
alanines are compatible with native folding (Cunningham and Wells 1989). In the N-
terminal domain, the disruption of first alpha-helix (a1) by a proline insertion completely 
blocked secretion of CDNF via both constitutive and regulatory pathways (Sun et al. 
2011). Additionally, transport from the ER to trans-Golgi network was defected and the 
mutated protein was accumulated in the ER. The secretion of mutated CDNF in which 
amino acids 15-18 (KEFL) or 19-22 (NRFY) (numbering according to the mature CDNF 
without signal sequence) of a1 were changed to AAAA was reduced via both constitutive 
and regulated pathways. For the C-terminal domain, a proline insertion in a7 decreased 
secretion of CDNF via regulatory pathway while secretion via constitutive pathway was 
unaltered. Mutations in a7 and a8 increased the O-linked glycosylation of T155 residue. 
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1.3 Endoplasmic reticulum and the maintenance of its homeostasis 
MANF and CDNF have been found to partially localize to the ER. Additionally, a 
function for MANF in ER stress has been demonstrated (see Chapter 1.3.4). ER is a cell 
organelle responsible for initiation of protein folding in the secretory pathway. 
Additionally, it serves as the primary intracellular calcium store and plays an important 
role in lipid synthesis. ER is a complex membrane network and takes up about one third of 
the  cell  volume.  Upon an  increased  need  for  folding  capacity,  the  ER membrane  can  be  
expanded (van Anken et al. 2003; Schuck et al. 2009). Secreted and membrane proteins 
are folded and maturated in the ER lumen and then transported to the trans-Golgi network. 
The quality of newly synthesized proteins is strictly monitored and misfolded proteins are 
either retained in the ER by molecular chaperones or directed towards ER-associated 
degradation (ERAD). 
Translation of mRNA into polypeptide is processed by ribosomes. Secretory proteins 
include hydrophobic N-terminal signal sequence bound by signal recognition particle 
(SRP) upon initiation of translation (reviewed in Guerriero and Brodsky, 2012). SRP 
binds to SRP receptor located in the ER membrane and the newly synthesized polypeptide 
enters into the ER lumen through a translocation complex. Following translocation, signal 
sequence is cleaved by signal sequence peptidase complex and oligosaccharides can be 
added to the polypeptide chains by a process known as N-linked glycosylation. 
Polypeptides then interact with chaperones to prevent their misfolding and aggregation. In 
the ER lumen, high levels of calcium are needed for both protein folding and protein-
chaperone interaction. High energy levels are required for maintaining Ca2+ levels and 
redox homeostasis as well as for chaperone function. Proteins are folded and dimerized 
through the oxidation of pairs of free thiols on cysteine residues, a process catalyzed by 
protein disulphide isomerases (PDI) (reviewed in Oka and Bulleid 2013). PDIs belong to a 
superfamily of thiol-disulphide oxidoreductases for which a characteristic feature is a 
CXXC motif (reviewed in Ellgaard and Ruddock 2005; Sevier and Kaiser 2006; Wouters 
et al. 2010). CXXC motif functions in the disulphide bond formation and may also take 
part in metal ion binding (Narindrasorasak et al. 2003; Horibe et al. 2004). 
1.3.1 Activation of unfolded protein response 
When the protein folding capacity in the ER is exceeded and unfolded or misfolded 
proteins are accumulated, ER homeostasis is disturbed. This state is referred as ER stress 
and induces unfolded protein response (UPR) (reviewed in Ron and Walter 2007; Hetz 
2012; Arensdorf et al. 2013). The main purpose of UPR is to retain ER homeostasis by 
decreasing the load of unfolded proteins. Novel protein synthesis is inhibited, folding 
capacity is increased by activation of chaperone expression, including the major ER 
chaperone GRP78 (glucose-regulated protein 78), and ER-directed mRNAs are degraded. 
Transcription of the genes encoding components of ERAD is induced to remove 
misfolded proteins from the ER by ubiquitin-proteasome degradation. If UPR fails to 
relieve ER stress and the accumulation of unfolded proteins persists, cell death pathways 
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are activated. UPR is associated with a variety of human diseases including diabetes and 
neurodegenerative disorders (reviewed in Wang and Kaufman 2012). 
The adaptive signalling cascades to restore ER homeostasis are activated through UPR 
transducer proteins IRE1 (inositol-requiring enzyme 1), PERK [PKR (RNA-dependent 
protein kinase) -like ER kinase] and ATF6 (activating transcription factor 6). Overview of 
UPR is presented in Figure 3. 
 
Figure 3. Overview of the three signalling branches of UPR. See main text for detailed description of the 
pathways. Reprinted with minor modifications by permission from Macmillan Publishers Ltd: Nature 
Reviews Drug Discovery (Hetz et al. 2013), copyright (2013). 
1.3.1.1 The conserved function of IRE1 and signalling through X-box binding protein-1 
(XBP1) 
The studies in yeast (Saccharomyces cerevisiae) have promoted the understanding how 
cells respond to ER stress. In yeast, ER stress signalling is mediated solely by IRE1, the 
most ancient branch of UPR conserved from yeast to mammals (Cox et al. 1993; Mori et 
al. 1993). IRE1 is an ER transmembrane sensor protein consisting of a luminal 
dimerization domain and a cytoplasmic part (Tirasophon et al. 1998). The cytoplasmic 
domain includes a protein kinase domain necessary for IRE1 activation in response to ER 
stress (Mori et al. 1993). IRE1 is oligomerized and activated by trans-autophosphorylation 
but whether other phosphorylation targets exist, is not currently known (Shamu and 
Walter 1996; Papa et al. 2003).  
The luminal domain of IRE1 binds GRP78 and dissociates from it upon ER stress 
(Bertolotti et al. 2000, Okamura et al. 2000). Oligomerization is repressed by binding to 
GRP78 (Oikawa et al. 2007) or prevented if the stress-sensing regions are deleted (Oikawa 
et al. 2005; Zhou et al. 2006). However, the GRP78 binding domain is dispensable for 
IRE1 activation upon ER stress suggesting that another alteration in the luminal domain of 
IRE1  is  necessary  for  its  activation  upon  ER  stress  (Kimata  et  al.  2004;  Oikawa  et  al.  
2007). Structural studies indicate that unfolded proteins bind to and are able to activate 
IRE1 directly (Credle et al. 2005; Oikawa et al. 2007). IRE1 was found to bind a 
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terminally unfolded protein and oligomerize providing further evidence to support this 
hypothesis (Gardner and Walter 2011). Thus, the association with GRP78 has been 
suggested to have a regulatory role rather than being the primary switch in IRE1-mediated 
induction of UPR (Kimata 2004; Credle 2005; Pincus et al. 2010; Gardner and Walter 
2011). 
In addition to the kinase activity, the cytoplasmic part of IRE1 exhibits 
endoribonuclease domain with dual function. First, it is involved in a conserved process 
termed regulated IRE1-dependent decay (RIDD) in order to degrade mRNAs in response 
to ER stress (Hollien and Weissman 2006; Hollien et al. 2009). RIDD involves mRNAs 
that traffic through ER and thus alleviates the burden for protein folding in ER (Hollien 
and Weissman 2006). However, whether a loose specificity of IRE1 endoribonuclease 
activity  is  directly  involved  or  does  the  activation  of  IRE1  lead  to  recruitment  of  other  
nucleases,  is  currently  unknown.  The  RNase  activity  of  IRE1 has  also  been  found to  be  
necessary for autoregulation of mammalian IRE1 mRNA (Tirasophon et al. 2000). 
Second consequence of IRE1 RNase activity is the cleavage of its sole known 
substrate, mRNA encoding a transcription factor Hac1 [ATF/CREB1 (cAMP responsive 
element binding protein 1) homologue] in yeast or XBP1 in metazoans (Cox and Walter 
1996; Yoshida et al. 2001; Calfon et al. 2002; Niwa et al. 2005). Hac1/XBP1 induces 
expression of ER chaperones and components of ERAD by binding to UPRE (unfolded 
protein response element) or ERSE (ER stress-response element) (Cox and Walter 1996; 
Travers et al. 2000; Yamamoto et al. 2007; see Chapter 1.3.1.4). While in yeast the Ire1-
Hac1 pathway is the sole inducer of UPR-targeted genes, in metazoans their expression is 
induced even if IRE1 or XBP1 is abolished (Calfon et al. 2002). In yeast, the site-specific 
cleavage of Hac1 mRNA excises a 252 nucleotide intron causing a frame shift as an 
unconventional splicing event (Cox and Walter 1996; Sidrauski and Walter 1997). Both 
unspliced (Hac1u) and spliced (Hac1s) are translated and able to activate UPRE, but Hac1u 
is rapidly degraded due to ubiquitin-targeting PEST-sequence in its C-terminal part (Cox 
and Walter 1996; Pal et al. 2007). Additionally, the presence of unspliced intron represses 
translation of Hac1u. In metazoans, a 23 (C. elegans and Drosophila)  or  26  (mammals)  
nucleotide intron is cleaved (Yoshida et al. 2001; Calfon et al. 2002). The splicing and 
thus  the  translation  of  XBP1  into  protein  is  the  key  event  in  UPR  (Calfon  et  al.  2002).  
Unspliced XBP1 (XBP1u) is suggested to have a role in negative feedback regulating 
IRE1 signalling by suppressing the translation of spliced XBP1 (XBP1s) (Yoshida et al. 
2006). 
In vertebrates, two IRE1 homologues have been described, IRE1a [also known as ER 
to nucleus signalling 1 (ERN1), hereafter referred as IRE1] (Tirasophon et al. 1998) and 
IRE1b (also  known  as  ERN2)  (Wang  et  al.  1998;  Iwawaki  et  al.  2001).  While  IRE1  is  
ubiquitously expressed (Tirasophon et al. 1998), IRE1b is detected in the gastrointestinal 
system only (Bertolotti et al. 2001) and functions in the attenuation of protein synthesis by 
promoting cleavage of 26S rRNA (Iwawaki et al. 2001). RNase activity of IRE1b is 
necessary for the inhibition of protein synthesis and directed specifically towards secretory 
proteins (Nakamura et al. 2011; Tsuru et al. 2013). 
In Drosophila, the unconventional splicing of Xbp1 by Ire1 is conserved (Ryoo et al. 
2007; Souid et al. 2007). Additionally, RIDD was first identified in cultured Drosophila 
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Schneider-2  cells  (Hollien  and  Weissman 2006).  Similar  to  mammals,  the  expression  of  
Drosophila homologue to GRP78, Hsc70-3 (Heat shock 70-kDa protein cognate 3), is 
upregulated in response to ER stress in Xbp1-dependent manner (Plongthongkum et al. 
2007; Loewen and Feany 2010; Malzer et al. 2013; Sekine et al. 2013). 
Under normal conditions, in both mouse and Drosophila,  spliced  form of  XBP1 has  
been detected specifically in tissues with high secretory load (Iwawaki et al. 2004; Souid 
et al. 2007; Sone et al. 2013; Ryoo et al. 2013). This indicates that the cells and tissues 
producing high levels of secretory proteins are susceptible to constant ER stress (reviewed 
in Hetz and Glimcher 2008). 
1.3.1.2 Attenuation of protein synthesis through PERK 
One of the mechanisms by which cell tries to overcome ER stress is the attenuation of 
overall protein synthesis. It is mediated through PERK phophorylating, and thus 
inhibiting, a-subunit of eIF2 (eukaryotic translation initiation factor 2) (reviewed in de 
Haro et al. 1996; Donnelly et al. 2013). PERK resides on the ER membrane and has a 
stress-sensing luminal domain, transmembrane domain and cytosolic part (Shi et al. 1998; 
Harding et al. 1999). The kinase domain is located in the cytosolic part and is activated by 
dimerization and trans-autophosphorylation (Harding et al. 1999; Bertolotti et al. 2000). 
PERK is maintained inactive by GRP78 binding to the luminal domain (Bertolotti et al. 
2000). In response to ER stress, GRP78 is dissociated from PERK allowing its activation. 
After restoring ER homeostasis, PERK is reassociated with GRP78 and dephosphorylated 
(Bertolotti et al. 2000).  
Although the phosphorylation of eIF2a inhibits  overall  protein  synthesis,  it  was  also  
found to selectively upregulate the translation of specific target mRNAs including ATF4 
(activating transcription factor 4) (Hinnebusch 1993; Harding et al. 2000). These mRNAs 
contain multiple inhibitory upstream ORFs and inactivation of eIF2a allows ribosomes to 
reach  the  ORF  with  a  start  codon  resulting  in  translation  of  a  functional  protein  
(Hinnebusch 1993). ATF4 activates transcription of genes that function in cell death, 
amino acid metabolism and resistance to oxidative stress. 
The attenuation of protein synthesis and selective translational activation are regulated 
to certain extent by dephosphorylation of eIF2a. GADD34/PPP1R15A (growth arrest and 
DNA damage protein 34/protein phosphatase 1, regulatory subunit 15A) and 
CReP/PPP1R15B (constitutive repressor or eIF2a phosphorylation/protein phosphatase 1, 
regulatory subunit 15B) are subunits of PP1 (protein phosphatase 1) that specifically 
counteract the inactivation of eIF2a by dephosphorylation (Connor et al. 2001; Novoa et 
al. 2001; Jousse et al. 2003). While CReP is constitutively expressed (Jousse et al. 2003), 
GADD34 expression is induced through ATF4 upon ER stress-mediated phosphorylation 
of eIF2a forming a negative feedback loop (Ma and Hendershot 2003; reviewed in Baird 
and Wek 2012). 
The Drosophila homologue of PERK, PEK (pancreatic eIF-2a kinase), phosphorylates 
eIF2a in vitro and localizes to ER membrane when transfected in mammalian cells 
(Pomar et al. 2003). Additionally, PEK-mediated phosphorylation of eIF2a was increased 
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in cells with induced ER stress indicating that the UPR branch mediated through PERK is 
conserved in Drosophila (Pomar et al. 2003). 
Invertebrate homologues of eIF2a phosphatases were only recently discovered 
(Malzer et al. 2013). The sole homologue to PP1 subunits in Drosophila, DmGadd34 (also 
known as CG3825), dephosphorylates eIF2a (Carra et al. 2010; Malzer et al. 2013). 
DmGadd34 is functionally more related to CReP due to the lack of transcriptional 
regulation upon ER stress. However, the translation of DmGadd34 was induced in 
response to ER stress. Overexpression of DmGadd34 induced the unconventional splicing 
of Xbp1 and thus ER stress similarly to the loss of endogenous PEK, suggesting that 
function of GADD34 and CReP is conserved in Drosophila (Malzer et al. 2013). 
The Drosophila homologue of ATF4, cryptocephal (crc), functions in ecdysone-
regulated events during larval molts and pupal metamorphosis (Hewes et al. 2000). During 
molts, larvae build a new cuticle and shed the old one. Synthesis of the new cuticle 
involves large amounts of secreted proteins and thus cause developmental ER stress. 
Similar to mammals, the protein level of crc/ATF4 is increased in response to ER stress 
(Kang et al. 2012). Interestingly, both mice and flies lacking ATF4 exhibited signs that 
indicate diabetes-like alterations (Seo et al. 2009). There is increasing evidence linking ER 
stress with the loss of b-cells in diabetes (reviewed in Lee and Ozcan 2014). 
In contrast to mammals, both Drosophila and C. elegans genomes lack apparent 
homologues of CHOP [C/EBP (CCAAT/enhancer binding protein) homologous protein], 
the main transcriptional target of ATF4 (Zinszner et al. 1998) (see Chapter 1.3.3). 
1.3.1.3 Upgrading the UPR by ATF6 
The third signalling branch of UPR is mediated by ATF6. In unstressed cells, ATF6 
resides on ER membrane and its ER luminal domain is bound by GRP78 (Haze et al. 
1999; Shen et al. 2002). Upon ER stress, ATF6 dissociates from GRP78 and is transported 
to Golgi. There, ATF6 is cleaved by Site-1 and Site-2 proteases (S1P and S2P) to release 
the cytosolic part of ATF6 (N-ATF6, ATF6f in Figure 3) (Haze et al. 1999; Ye et al. 
2000). N-ATF6 has transcriptional activity and contains a DNA binding domain. After 
cleavage N-ATF6 is localized to nucleus where it binds to ERSE (Yoshida et al. 1998) in 
presence  of  NF-Y [nuclear  transcription  factor  Y,  also  known as  CBF (CCAAT-binding  
transcription factor)] and activates expression of target genes, e.g. encoding for XBP1, 
GRP78 and CHOP (Haze et al. 1999; Yoshida et al. 2000). N-ATF6 induces expression of 
ER chaperones and ERAD components (Wu et al. 2007). ATF6 branch has been 
hypothesized to be responsible for maintaining mRNA level of XBP1 in such a way that a 
rapid response following activation of IRE1 is possible (Yoshida et al. 2003). 
In mammals, a structural homologue to ATF6 was identified and named ATF6b (Haze 
et al. 2001). While N-ATF6b has transcriptional activity and binds to ERSE, it seems to 
inhibit the transcriptional activity of N-ATF6, probably to fine-tune the transcriptional 
regulation during UPR (Thuerauf et al. 2004; Thuerauf et al. 2007). 
Invertebrate genomes include only one homologue to ATF6. The Drosophila 
homologue, CG3136, has high homology at amino acid level and contains the DNA 
binding, transmembrane and ER-luminal domains. However, its putative involvement in 
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Drosophila UPR  has  not  yet  been  studied  (Ryoo  and  Steller,  2007;  Rasheva  and  
Domingos, 2009). The C. elegans homologue, atf-6, is dispensable for worm development 
and functional UPR, but is partially redundant with Ire1 pathway (Shen et al. 2005). 
1.3.1.4 Activation of chaperone expression through specific cis-acting elements 
In response to ER stress, the expression of chaperones is induced through three different 
cis-acting elements found in their promoter regions, UPRE (Wang et al. 2000; Yoshida et 
al. 2003), ERSE (Roy and Lee 1995; Roy et al. 1996; Yoshida et al. 1998) and ERSE-II 
(Kokame et al. 2001; Yamamoto et al. 2004). UPRE contains consensus sequence 
TGACGTGG/A and is the preferential binding site for XBP1s (Yoshida et al. 2001). The 
consensus of ERSE element is CCAAT-N(9)-CCACG and N-ATF6 was found to activate 
the expression of ER stress-inducible genes by binding to the CCACG sequence (Yoshida 
et al. 2000). Binding of N-ATF6 to ERSE requires NF-Y bound to CCAAT (Yoshida et al. 
2000). In the presence of NF-Y, XBP1s is also able to bind to ERSE in similar manner to 
N-ATF6, but with a lot lower affinity (Yamamoto et al. 2004). The ERSE-II element with 
consensus ATTGG-N-CCACG has been shown to be activated by both N-ATF6 and 
XBP1s  (Yamamoto  et  al.  2004).  In  addition,  Luman/CREB3 (cAMP responsive  element  
binding protein 3), another ER stress-inducible factor, was found to associate with ERSE-
II element (Liang et al. 2006). 
1.3.2 Clearing the misfolded proteins by ERAD 
When unfolded and misfolded proteins begin to accumulate in the ER, they are degraded 
by a cytosolic complex called ubiquitin-proteasome system. Misfolded proteins are bound 
by chaperones that direct their transport from ER to cytoplasm. The mechanism by which 
misfolded proteins are translocated back to the cytoplasm is known as ERAD (reviewed in 
Meusser et al. 2005; Stolz and Wolf 2010). ERAD is also used to regulate certain enzyme 
levels. 
The first step in ERAD is to recognize misfolded region and it is mediated by 
chaperones. The quality of glycosylated proteins is monitored by chaperone-like lectins. 
After recognized, the misfolded protein is polyubiquitinated, usually in lysine residues by 
an ubiquitin ligase (E3). Ubiquitin activating enzyme (E1) and ubiquitin conjugating 
enzyme (E2) activate ubiquitins prior binding to a misfolded protein. The ubiquitinated 
protein is removed from the ER either together with the surrounding ER-membrane or 
through a retrotranslocon and escorted to 26S proteasome. ERAD is divided into three 
subpathways depending on the subcellular location of the misfolded region. Protein 
misfolding in the ER-luminal part is degraded by ERAD-L, transmembrane part by 
ERAD-M and cytoplasmic side by ERAD-C. The interacting chaperone, ubiquitin ligase 
and retrotranslocation components are selected accordingly. 
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1.3.3 ER stress and cell death 
Cells that encounter ER stress activate signalling cascades through the three branches of 
UPR in order to return the homeostasis in ER. If cell fails to overcome ER stress, it enters 
the apoptotic pathway and is destined to die. All three branches of UPR regulate signalling 
pathways leading to cell death. Although signalling pathways involved in ER stress-
related cell death have been identified, the molecular mechanisms behind it are still poorly 
understood. 
BCL-2 protein family plays a critical role in apoptosis and consists of several pro- and 
anti-apoptotic proteins (reviewed in Tait and Green 2010). Characteristic for these proteins 
is a BCL-2 homology (BH) domain. Apoptosis is initiated upon activation of pro-
apoptotic multidomain BAX and BAK (BH antagonist or killer). Multimerized BAX and 
BAK promote the permeabilization of the outer mitochondrial membrane allowing the 
release of cytochrome c into cytoplasm and activation of the caspase cascade. BAX and 
BAK play a crucial role in the ER stress-induced cell death which is blocked in mouse 
embryonic fibroblasts (MEFs) derived from mice lacking both endogenous BAX and 
BAK (Wei et al. 2001). BH3-only proteins are upstream regulators of BAX and BAK and 
their expression is upregulated by UPR. BH3-only proteins also promote apoptosis by 
inhibiting anti-apoptotic BCL-2 proteins. 
Two BCL-2 family proteins have been identified in Drosophila genome, pro-apoptotic 
Debcl (death executioner Bcl-2 homologue) and anti-apoptotic Buffy (Chen and Abrams, 
2000). Buffy is localized to the ER while Debcl is found in the mitochondria (Doumanis et 
al. 2007). In contrast to mammalian BAX and BAK, the Drosophila Debcl has only a 
limited role in apoptosis (Sevrioukov et al. 2007; Galindo et al. 2009). Yet, a role for 
Debcl or Buffy has not been reported in Drosophila UPR. Homologues to BH3-only 
proteins have not been identified in the Drosophila genome (Quinn et al. 2003). 
Phosphorylation of eIF2a by PERK leads to translational upregulation of ATF4. One 
of the main targets of ATF4 is the apoptosis-promoting CHOP (also known as 
GADD153). The mechanism by which CHOP promotes apoptosis is still unclear. CHOP 
is known to downregulate the expression of anti-apoptotic BCL-2 (McCullough et al. 
2001) and overexpression of BCL-2 was found to block CHOP-induced apoptosis 
(Matsumoto et al. 1996). CHOP also upregulates the expression of eIF2a phosphatase 
GADD34 as well as pro-apoptotic BH3-only proteins BIM (BCL-2-interacting mediator 
of cell death) and PUMA (p53 upregulated modulator of apoptosis) (Marciniak et al. 
2004; Puthalakath et al. 2007; Galehdar et al. 2010). 
1.3.3.1 IRE1-mediated regulation of apoptosis 
The activation of IRE1 regulates apoptosis by its downstream targets JNK (c-JUN N-
terminal kinase), ERK (extracellular signal-regulated kinase), p38 and NF-kB (nuclear 
factor kappa-light-chain-enhancer of activated B cells). The recruitment of TRAF2 [TNFR 
(tumor necrosis factor receptor)-associated factor 2] by cytosolic domain of IRE1 results 
in activation of ASK1 (apoptosis signal-regulating kinase 1), a member of MAPK 
(mitogen-activated protein kinase) family. JNK is a downstream target of ASK1 and its 
REVIEW OF THE LITERATURE 
 
 
 
 
21
activation is an important event in induction of apoptosis (Urano et al. 2000; Nishitoh et 
al. 2002). Phosphorylation by JNK inhibits anti-apoptotic BCL-2 (Pattingre et al. 2009) 
and activates pro-apoptotic BIM (Lei and Davis 2003). 
NF-kB is a regulator of both mitochondrial and death receptor apoptotic pathways. 
NF-kB transcriptional complex, consisting of NF-kB/Rel (Relish) transcription family 
members, regulates transcription of genes involved in innate immunity, inflammation and 
apoptosis (reviewed in Hoesel and Schmid 2013). NF-kB is maintained inactive by IkB 
(inhibitor of NF-kB)  and  activated  by  phosphorylation  of  IkB by IKK (inhibitor kB 
kinase). Inhibition of NF-kB was found to suppress ER stress-induced cell death in vitro 
(Hu et al. 2006) and activation of NF-kB requires phosphorylation of eIF2a (Jiang et al. 
2003). IRE1 is also essential for the ER stress-induced activation of NF-kB by forming a 
complex with IKK through TRAF2 (Hu et al. 2006).  
1.3.4 Role of MANF in ER stress 
The mammalian and Drosophila MANF has been found to localize to ER (Mizobuchi et 
al. 2007; Apostolou et al. 2008; Tadimalla et al. 2008; Palgi et al. 2012). The C-terminus 
of MANF and CDNF resembles the canonical ER retention signal sequence, KDEL. This 
putative ER retention signal of MANF/CDNF is conserved: RTDL in human and mouse 
MANF, KTEL in human CDNF and RSEL in Drosophila Manf. RTDL motif has been 
shown to be responsible for retaining MANF in the ER and evidence suggests an 
interaction  with  KDEL-R  (KDEL  receptor)  (Glembotski  et  al.  2012;  Henderson  et  al.  
2013). Three KDEL-R genes are found in human genome (reviewed in Capitani and 
Sallese 2009). These receptors bind C-terminal KDEL-containing proteins in Golgi and 
facilitate their trafficking back to ER. In vitro study revealed that the RTDL sequence 
binds KDEL-R with lower affinity in comparison to canonical KDEL sequence (Raykhel 
et al. 2007). The different affinity between KDEL and RTDL sequences has been 
suggested to have crucial role in MANF secretion (Glembotski 2011). This hypothesis is 
supported by in vitro studies showing that mutated MANF-KDEL, in which the last four 
C-terminal amino acids (RTDL) were replaced with KDEL sequence, was retained 
intracellularly more efficiently than the wild type MANF (Glembotski et al. 2012). 
Additionally, deleting the RTDL sequence has been shown to increase MANF secretion 
(Glembotski et al. 2012; Oh-Hashi et al. 2012; Henderson et al. 2013). 
Silencing of MANF made cells more susceptible to and, vice versa, overexpression of 
MANF protected cells against tunicamycin-induced ER stress-related cell death 
(Apostolou et al. 2008). Murine MANF showed high expression level in secretory cells 
that are prone to ER stress due to high traffic of proteins through the ER (Mizobuchi et al. 
2007; Lindholm et al. 2008). The protective role against ER stress-related cell death 
together with the expression studies support the suggested chaperone-like functions for 
MANF (Lindholm et al. 2008). Additionally, MANF has been found to bind misfolded 
proteins in vitro (Hartley et al. 2013). 
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1.3.4.1 ER stress induces expression of MANF 
Microarray analyses have demonstrated that the expression of MANF is altered in 
response to ER stress. Tunicamycin, thapsigargin and dithiothreitol, agents that induce ER 
stress, were found to upregulate MANF expression in MEF, HeLa, U2OS (human 
osteosarcoma) and HEK293 (human embryonic kidney 293) cells in vitro (Lee et al. 2003; 
Apostolou et al. 2008) as well as in Drosophila adult flies in vivo (Girardot et al. 2004). In 
MEFs, the upregulation of MANF by tunicamycin treatment was lost in XBP1 knockout 
cells in which ATF6 was silenced suggesting that the induction of MANF expression is 
mediated through XBP1 or ATF6 (Lee et al. 2003). Later studies revealed that 
overexpression of activated ATF6 or XBP1 in cardiomyocytes induced MANF expression 
in vitro (Tadimalla et al. 2008) and that ATF6 expression led to upregulation of MANF 
expression in the heart of transgenic mouse in vivo (Belmont et al. 2008). Additionally, 
both N-ATF6 and XBP1s increased MANF promoter activity in response to thapsigargin-
induced ER stress in Neuro2a cells (Oh-Hashi et al. 2013). 
Expression of MANF has also been found to be upregulated in response to expression 
of unfolded proteins (Mizobuchi et al. 2007; Nundlall et al. 2010). Pancreatic b-cells 
isolated from Insulin-Akita mouse showed increased MANF level (Mizobuchi et al. 2007). 
This diabetes mellitus mouse strain carries C96Y mutation in Ins2 gene (Ins2C96Y) that 
prevents the folding of proinsulin (Yoshioka et al. 1997; Wang et al. 1999; reviewed in 
Ron 2002). Pancreatic b-cells expressing high levels of insulin, a secretory protein, are 
already susceptible to ER stress (Iwawaki et al. 2004). The expression of Ins2C96Y leads to 
accumulation of unfolded proinsulin causing continuous ER stress including activation of 
ATF6 and XBP1 (Nozaki et al. 2004). Additionally, chondrocytes isolated from mouse 
model of multiple epiphyseal dysplasia (MED) showed increased MANF expression 
(Nundlall et al. 2010). This transgenic mouse strains carries a V194D mutation in 
Matrilin 3 (Matn3) encoding gene causing folding defect in the A-domain of Matn3 
(Cotterill et al. 2005; Leighton et al. 2007). Matn3V194D mutant form is retained in the ER 
and  activates  UPR  (Cotterill  et  al.  2005;  Leighton  et  al.  2007).  Matn3V194D mutant has 
been shown to reduce proliferation and dysregulate apoptosis in chondrocytes (Leighton et 
al. 2007). Noting that the silencing of MANF increased cell proliferation, protected 
glucose-deprived cells from apoptosis and thus enhanced the survival of cultured HeLa 
cells (Apostolou et al. 2008), Hartley et al. (2013) suggested that MANF could have a role 
either in initiation or progress of MED. 
Another indication of a link between ATF6/XBP1 and MANF was found in a study of 
in vitro maturation (IVM) oocytes (Wang et al. 2011). IVM is associated with lower rates 
of blastulation and pregnancy in comparison to routine in vitro fertilization (Lee et al. 
2008). In comparison to in vivo matured oocytes, MANF mRNA level was increased in 
IVM oocytes and two-cell embryos as well as in the brain tissue of fetal and newborn mice 
(Wang et al. 2011). MANF protein levels together with mRNA levels of ATF6 and XBP1 
were increased in the brain tissues in corresponding time points suggesting an induction of 
ER stress response and subsequent upregulation of MANF expression. However, brain 
morphology or cognition was not significantly altered. 
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Murine MANF has been found to be upregulated through ERSE-II located in its 
promoter region at positions −134 to −124 (Mizobuchi et al. 2007; Tadimalla et al. 2008). 
Both XBP1/ATF6 and NF-Y binding sites are required for induction of MANF expression 
upon ER stress (Mizobuchi et al. 2007). MANF promoter also includes the canonical 
ERSE at position −492 to −473 but was found to be far less efficient for inducing MANF 
expression in response to ER stress (Tadimalla et al. 2008). Interestingly, the MANF 
ERSE-II completely matches the first ERSE-II element discovered in promoter region of 
HERP [also known as HERPUD1 (homocysteine-inducible, ER stress-inducible, 
ubiquitin-like domain member 1)] (Kokame et al. 2001). HERP encodes an ubiquitin-
domain ER membrane protein and is predicted to function in the ERAD pathway (Kokame 
et al. 2001, Hori et al. 2004; Schulze et al. 2005). Luman/CREB3 was found to contribute 
to the ER stress-induced expression of HERP (Liang et al. 2006) but not MANF (Oh-
Hashi et al. 2013). Expression of another component of ERAD complex, VIMP (VCP-
interacting membrane protein, also known as selenoprotein S), is suggested to be induced 
upon ERSE-II-like element located in its promoter region (Schulze et al. 2005). Taken 
together, ERSE-II might regulate the protein quality control and degradation of misfolded 
proteins during ER stress suggesting that MANF has also a role in these functions 
(Mizobuchi et al. 2007). 
1.3.4.2 MANF expression is essential for pancreatic b-cells 
Recently, a knockout MANF mouse model was reported (Lindahl et al. 2014). Both global 
and pancreatic-specific knockout of MANF resulted in severe diabetic phenotype with 
insulin deficiency and progressive loss of b-cells. MANF knockout mice were postnatal 
viable but their health was declined drastically soon after reaching adulthood. In 
accordance with the previous diabetes models (reviewed in Lee and Ozcan 2014), the loss 
of b-cells in MANF knockout mice was mediated by decreased proliferation and increased 
apoptosis (Lindahl et al. 2014). Overexpression of MANF enhanced proliferation and 
inhibited cell death of b-cells. Moreover, the loss of MANF resulted in progressive UPR 
in vivo.  These findings are in line with the in vitro studies showing that overexpression 
protected cells against ER stress-induced cell death (Apostolou et al. 2008). Additionally, 
silencing of MANF made cells more vulnerable to ER stress-induced cell death in vitro 
(Apostolou et al. 2008). This could explain why b-cells,  known to  be  susceptible  to  ER 
stress  because  of  the  high  levels  of  secretory  proteins  (Iwawaki  et  al.  2004),  are  lost  if  
MANF expression is abolished (Lindahl et al. 2014). 
1.3.4.3 MANF interacts with the major ER chaperone GRP78 
GRP78 [also known as BiP (binding immunoglobulin protein) and HSPA5 (heat shock 70 
kDa protein 5); Haas and Wabl 1983; Munro and Pelhan 1986; reviewed in Lee 1987; 
Weng et al. 2011; Pfaffenbach and Lee 2011] is a member of the heat shock protein 70 
(HSP70) family and associates with other ER-resident proteins. GRP78 is the major ER 
chaperone assisting the folding of newly synthesized proteins and consists of three 
domains: ATPase, peptide-binding and C-terminal domains. Overexpression of GRP78 
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was found to increase Ca2+ storage capacity independent of the peptide-binding domain 
and thus its chaperone activity towards other proteins (Lievrémont et al. 1997). In 
addition, GRP78 associates with ER stress response transducer proteins, IRE1, PERK and 
ATF6, and maintains them inactive. GRP78 has also been shown to have cytoprotective 
and anti-apoptotic properties. ER stress, induced by a presence of unfolded protein, 
hypoxia or ischemia (see Chapter 1.3.4.5), has been shown to increase expression of 
GRP78. Transcriptional activity of XBP1s activates GRP78 expression through ERSE 
element found in the promoter region of GRP78. 
Mammalian MANF was found to co-localize with GRP78 in the ER in cardiomyocytes 
(Mizobuchi et al. 2007; Tadimalla et al. 2008). MANF was also found to interact directly 
with GRP78 in Ca2+-dependent manner (Glembotski et al. 2012). MANF binding to 
GRP78  was  released  upon  a  treatment  with  thapsigargin,  an  inhibitor  of  SERCA  
(sarco/endoplasmic  reticulum  calcium  transporting  ATPase)  used  to  deplete  ER  calcium  
and induce ER stress, leading to increased secretion of MANF. Overexpression of GRP78 
in cardiomyocytes decreased the secreted portion of MANF independent of ER retention 
signal (Glembotski et al. 2012). 
The loss of RTDL sequence did not affect the thapsigargin-induced secretion of 
MANF in cultured cardiomyocytes (Glembotski et al. 2012). However, an in vitro study in 
SH-SY5Y neurons revealed that RTDL sequence was essential for the thapsigargin-
induced secretion of MANF suggesting a cell type-dependent role of MANF (Henderson 
et al. 2013). The RTDL sequence was found to mediate MANF binding to cell surface, 
modulated by KDEL-R (Henderson et al. 2013). The cell type-dependent requirement for 
ER retention signal in thapsigargin-induced secretion of MANF might be due to cell-
specific expression of different KDEL-Rs (Henderson et al. 2013). KDEL-R and GRP78 
probably  maintain  the  ER  residence  and  regulate  the  secretion  of  MANF  together  
(Glembotski et al. 2012). 
1.3.4.4 Atypical secretion of MANF upon ER stress 
The increased secretion of MANF in response to ER stress is atypical for ER stress-
induced molecules that are usually further retained in the ER (Glembotski 2011). A 
competence model was suggested by Glembotski (2011). MANF containing an unique 
RTDL sequence as ER retention signal has weaker affinity to KDEL-R than the canonical 
KDEL sequence found in the majority of ER-resident proteins (Raykhel et al. 2007). 
Under normal conditions, MANF mainly binds KDEL-Rs and is retained in the ER. Upon 
ER stress, the expression of ER-resident proteins is upregulated and more KDEL-
containing proteins enter the Golgi. However, the level of KDEL-Rs is not affected by ER 
stress (Llewellyn et al. 1997). MANF, with lower affinity to KDEL-R, loses its binding to 
the receptors and is more secreted. Thus, MANF could act as an extracellular signalling 
molecule and signal to neighbouring cells what is the state of the secreting cell. 
Additionally, MANF could bind to the cell membrane and activate cell survival promoting 
pathways cis.  
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1.3.4.5 MANF and ischemia 
Ischemia is a pathological state in which blood supply to tissues is disturbed and 
subsequently leads to hypoxia i.e. deprivation of oxygen. ER stress is induced by an 
ischemic injury (reviewed in DeGarcia and Montie, 2004) and the protein folding in the 
ER lumen requires molecular oxygen (Tu and Weissman, 2002). Drosophila embryos 
homozygous for a null allele of DmManf showed tolerance to a hypoxic environment 
(Azad et al. 2012; P. Azad, personal communication; M. Palgi, personal communication). 
Hypoxia increased murine MANF mRNA level in vitro (Romero-Ramirez et al. 2004). 
Expression of MANF mRNA was transiently increased after ischemic insult and status 
epilepticus in rat brains (Lindholm et al. 2008) and MANF protein expression was 
increased upon ischemic brain injury in rats (Apostolou et al. 2008; Yu et al. 2010). 
Ischemia-induced MANF expression was found in activated microglial cells and 
astrocytes which lack endogenous MANF expression under normal physiological 
conditions (Shen et al. 2012). Increased MANF expression preceded the upregulation of 
CHOP expression in response to ischemia-induced ER stress (Yu et al. 2010). 
1.3.4.6 Mammalian MANF and CDNF are neuroprotective in vivo 
Both mammalian MANF and CDNF, when injected as recombinant proteins into striatum, 
have been shown to protect and repair midbrain dopaminergic neurons in the 6-OHDA (6-
hydroxydopamine) rat model of Parkinson’s disease (PD) in vivo (Lindholm et al. 2007; 
Voutilainen et al. 2009). Injected recombinant CDNF was also protective and 
neurorestorative for the tyrosine hydroxylase (TH) -positive cells in the MPTP (1-methyl-
4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of PD (Airavaara et al. 2012). TH is 
the rate-limiting enzyme in dopamine synthesis and is commonly used as a marker for 
dopaminergic cells (reviewed in Daubner et al. 2011). CDNF has been found to be 
protective in the 6-OHDA rat model also when gene therapy with a recombinant adeno-
associated  viral  (AAV)  serotype  2  vector  encoding  CDNF  was  used  (Bäck  et  al.  2013).  
Additionally, chronic infusion of CDNF but not MANF after the 6-OHDA treatment was 
protective towards degeneration of dopaminergic neurons in vivo (Voutilainen et al. 2011). 
Prelesional  administration  of  either  a  recombinant  MANF  protein  or  AAV  vector  
encoding MANF was found to protect cerebral cortex neurons against ischemia in rats and 
prevent cell death in ischemic cortex (Airavaara et al. 2009; Airavaara et al. 2010). 
Extracellularly added recombinant MANF was found to protect cultured cardiomyocytes 
from simulated ischemia (Tadimalla et al. 2008) and protected from tissue damage in an in 
vivo ischemia mouse model (Glembotski et al. 2012). 
A protective role for MANF was also demonstrated in a spinocerebellar ataxia 17 
(SCA17) knockin mouse model (Yang et al. 2014). In SCA17, an expanded polyglutamine 
repeat in TATA box binding protein (TBP) causes age-dependent neurodegeneration 
(reviewed in Orr and Zoghbi, 2007). In SCA17 knockin mice, chaperone activity together 
with MANF expression was decreased (Yang et al. 2014). The reduced MANF level was 
found to be mediated by decreased transcriptional activity through Xbp1s. Overexpression 
of MANF protected from mutated TBP toxicity. Additionally, MANF was found to 
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increase the phosphorylation of protein kinase C (PKC) in PC12 cells and in vivo 
suggesting that MANF is involved in the signalling pathways activated by PKC. 
1.3.4.7 MANF and CDNF repress inflammatory response 
In response to ER stress caused by an ischemic injury in the nervous system, astrocytes 
secrete pro-inflammatory and anti-inflammatory cytokines together with trophic factors to 
modify the surrounding microenvironment. All three branches of mammalian UPR 
contribute to the inflammatory process by regulating the activity of NF-kB, the main 
mediator of pro-inflammatory response. Astrocyte damage leads to excessive cytokine 
release which may have a destructive effect on the survival of neurons. The roles of 
MANF and CDNF for ER stress-induced inflammatory cytokine expression in cultured rat 
astrocytes were studied (Cheng et al. 2013; Zhao et al. 2013b). In the first study (Cheng et 
al. 2013) tunicamycin was used to induce ER stress and subsequent expression and 
secretion of pro-inflammatory cytokines. Overexpression of CDNF in rat primary 
astrocytes suppressed both mRNA expression and secreted protein levels of pro-
inflammatory cytokines IL1-b (interleukin-1 beta), IL-6 (interleukin-6) and TNF-a (tumor 
necrosis factor alpha) (Cheng et al. 2013). In further studies, the overexpression of CDNF 
showed cytoprotective effect against lipopolysaccharide-induced inflammation by 
suppressing phosphorylation of JNK but not p38 or ERK pathways (Zhao et al. 2013a). In 
the second study (Zhao et al. 2013b), oxygen-glucose deprivation (OGD) was used to 
induce inflammatory response monitored by the increased expression and secretion of pro-
inflammatory cytokines. In addition, OGD induces expression of GRP78, indicating 
activation of ER stress response, and p65 subunit of NF-kB. When cells were incubated 
with extracellular recombinant MANF prior to OGD, the inflammatory response was 
significantly reduced and cell viability increased. Additionally, preincubation of the OGD 
cells with MANF-containing medium repressed the induction of GRP78 and p65 protein 
expression (Zhao et al. 2013b). 
1.3.4.8 Valproic acid (VPA) induces expression of MANF and CDNF 
VPA is used in treatment of epilepsy, mood disorders and migraine and has been reported 
to attenuate effects of oxidative and ER stresses (Lee et al. 2014). VPA treatment resulted 
in upregulation of CDNF and MANF expression in vivo and in vitro (Niles et al. 2012; 
Almutawaa et al. 2014). VPA acts through MAPK/ERK, phosphatidylinositol 3-
kinase/Akt and Wnt/b-catenin pathways and it was suggested that these signalling 
pathways could be involved in the induction of MANF/CDNF expression (Monti et al. 
2009; Almutawaa et al. 2014). Additionally, upregulation of MANF expression together 
with its protective role towards ER stress-related cell death (Apostolou et al. 2008) could 
contribute to the VPA-mediated relieve of ER stress (Almutawaa et al. 2014). 
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1.4 Selected highlights of Drosophila as a model organism 
Drosophila has served as a model organism for over a century (reviewed in Bier 2005; 
Rincon-Limas et al. 2012). One of its key features is the modest genome size consisting of 
approximately 14,000 protein coding genes (http://flybase.org, FB2014_01 release; 
Adams et al. 2000; McQuilton et al. 2012). The easy and relatively inexpensive husbandry 
together with the sophisticated genetic tools makes Drosophila an attractive in vivo model 
to study not only the biological processes but also human diseases. Although diverging 
early during evolution of metazoans, the Drosophila genome includes homologues for 
75% of identified human disease genes (Reiter et al. 2001). 
1.4.1 Overview of the Drosophila life cycle 
Drosophila melanogaster is a holometabolous species which undergoes complete 
metamorphosis with a four-stage development (described e.g. in Ashburner et al. 2005). 
The  embryos  hatch  approximately  one  day  after  fertilization.  During  the  larval  stage  
growth is rapid and the larvae molt twice in around 24 h intervals dividing the larval stage 
into three instars. Two days after reaching the 3rd instar, larvae wander away from the food 
and form an immobile pupa. The metamorphosis of larvae into adults occurs during the 
pupal stage and after 4–5 days, the adults eclose. Altogether, the development of 
Drosophila lasts 9–10 days. 
1.4.2 Activation or silencing of target gene by binary expression system 
One of the most important genetic tools of Drosophila model is the binary UAS (upstream 
activation sequence)/GAL4 expression system adopted from yeast (Brand and Perrimon 
1993). The principle of UAS/GAL4 system is illustrated in Figure 4. UAS contains 
binding sites for GAL4, a yeast transcription factor. UAS fly lines are created by 
generating transgenic flies using a construct in which the target gene (i.e. marker or the 
gene of interest) is introduced downstream of UAS. Target gene expression is activated by 
crossing UAS-[target gene] flies to enhancer-GAL4 flies. In the absence of GAL4, target 
gene remains inactive although the flanking regions of the transgene insertion site may 
activate transcription independent of UAS (Potter et al. 2010). GAL4 lines can be created 
either by placing the GAL4 gene under specific promoter (e.g. heat shock promoter) or by 
inserting a promoterless GAL4 gene into the fly genome. The latter will use the genomic 
enhancers of the flanking region and has enabled establishment of thousands of GAL4 
lines by mobilizing the GAL4 transgene (Brand and Perrimon 1993; Hayashi et al. 2002). 
These insertions are referred as “enhancer trap” lines. 
Further developments of UAS/GAL4 system have been established for extremely 
refined genetic manipulations, e.g. MARCM  (mosaic  analysis  with  a  repressible  cell  
marker) system by Lee and Luo (1999) and Q system by Potter et al. (2010) (reviewed in 
Duffy 2002). The UAS/GAL4 system is also adopted for gene knockdown studies by 
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RNAi (RNA interference) process (Piccin et al. 2001; Kalidas and Smith 2002). In RNAi, 
the mRNA of target gene is degraded by double-stranded RNA (dsRNA) (Fire et al. 
1998). In UAS-RNAi flies, dsRNA is introduced under UAS and can be expressed by 
GAL4 driver for tissue-specific inactivation. Transgenic genome-wide Drosophila RNAi 
libraries have been established and maintained in stock centers (Dietzl et al. 2007; 
http://www.shigen.nig.ac.jp/fly/nigfly/). 
 
Figure 4. Schematic presentation of the binary UAS/GAL4 in vivo expression system. See text for 
details. P stands for 5’- and 3’- inverted repeats of P-element between which the transgene is located. 
Drawings based on Brand and Perrimon (1993), Duffy (2002), and Dietzl et al. (2007). 
1.4.3 Examples of ER stress models in Drosophila 
1.4.3.1 Autosomal dominant retinitis pigmentosa (ADRP) and rhodopsin-1 (Rh-1) 
The first Drosophila model focusing to study UPR in human disease was established in a 
study of Rh1 [also known as ninaE (neither inactivation nor afterpotential E)] (Ryoo et al. 
2007). Mutated Rh1 (Rh1G69D) was previously reported to cause retinal degeneration and 
disturb ER-Golgi transport displaying similar molecular and phenotypic characteristics to 
human ADRP (Colley et al. 1995; Kurada and O’Tousa 1995). Ryoo et al. (2007) cloned 
Rh1G96D allele into the UAS construct for tissue-specific expression. UPR was discovered 
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to contribute to the retinal degeneration caused by ectopic expression of Rh1G96D, detected 
by the unconventional splicing of Xbp1 and upregulation of Hsc70-3, the Drosophila 
homologue of GRP78. 
1.4.3.2 Diabetes mellitus and Ins2C96Y 
A  fly  model  corresponding  to  Insulin-Akita  mouse  was  recently  developed  (Park  et  al.  
2014; see Chapter 1.3.4.1). Both wild type and mutated (InsC96Y) human proinsulin 
encoding constructs were introduced to Drosophila for conditional expression by 
UAS/GAL4 system. Ectopic expression of InsC96Y in the Drosophila eye resulted in retinal 
degeneration similar to ADRP model (Ryoo et al. 2007, see also previous chapter). The 
unconventional splicing of Xbp1 was  detected  and  mRNA  levels  of  PEK, Hsc70-3 and 
Xbp1 were upregulated indicating the presence of ER stress. Similar to Insulin-Akita 
mouse model (see Chapter 1.3.4.1), a microarray analysis revealed that DmManf 
expression was upregulated in response to expression of InsC96Y in the eye imaginal disc. 
1.4.3.3 Alzheimer’s disease - Amyloid-b toxicity 
Indirect links between pathogenesis of Alzheimer’s disease and alterations in ER function 
have been found, e.g. increased phosphorylation of eIF2a as well as elevated mRNA 
levels of GRP78 and XBP1s (Katayama et al. 1999; Chang et al. 2002; Kakimura et al. 
2002; Hoozemans et al. 2005; Lee et al. 2010). In a recently established, improved 
Drosophila model of Alzheimer’s disease, GAL4-directed expression of a construct 
encoding two copies of human amyloid-beta peptide (Ab) under UAS sequence caused 
neurotoxicity (Casas-Tinto et al. 2011). The splicing of Xbp1 and expression of Hsc70-3 
were induced upon Ab expression indicating ER stress. In this model, overexpression of 
either endogenous Drosophila Xbp1 or the spliced form of murine XBP1 rescued the Ab-
related neurotoxicity. Additionally, murine Xbp1s was found to induce expression of 
Hsc70-3 in Drosophila. 
1.4.4 Genetic screens in the Drosophila model 
A unique advantage of Drosophila as a model system is the possibility to perform large-
scale genetic screens in vivo (reviewed in St. Johnston 2002). A screen can be carried out 
to identify genes involved in a particular cellular or developmental process. Additionally, 
they can be used to discover interacting partners of certain proteins or novel components 
of already established signalling pathways. The beauty of Drosophila genetic screens was 
revealed by the Nobel-prize winning mutagenesis screen to identify genes modulating the 
patterning of the Drosophila embryo (Nüsslein-Volhard and Wieschaus 1980). In this 
screen, mutations and thus genes affecting the normal patterning of the embryo were 
identified by altered embryonic morphology – one of the main reasons for its success was 
the simplicity of the phenotype detection. 
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In addition to mutations, modifier screens performed in Drosophila model have been 
fruitful. One advantageous strategy is to use flies heterozygous for a recessive mutation of 
the gene of interest and screen for enhancers and suppressors that cause a phenotype in the 
heterozygous – i.e. sensitised – background. This approach also allows identification of 
lethal mutations. After the establishment of UAS/GAL4 system (Brand and Perrimon 
1993) and its derivatives, e.g. libraries of EP lines for gain-of-function (Rørth 1996) and 
UAS-RNAi lines for loss-of-function (Dietzl et al. 2007), more delicate tools exist to 
identify genetic modifiers. Moreover, genomic deletions of different sizes (also known as 
deficiencies, Merrill et al. 1988) can be assessed to roughly identify the chromosomal 
location of modifier genes and then narrowed down to found the actual interacting genes. 
Combining the available genetic tools enables identification of almost any genetic 
interaction. 
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2 AIMS OF THE STUDY 
The MANF/CDNF family of neurotrophic factors has been characterized by their 
protective and neurorestorative functions. Based on animal model and in vitro studies, 
MANF and CDNF may have a potential as a treatment for neuronal degeneration. 
Currently, the drugs used to treat neurodegenerative diseases only alleviate the symptoms 
and are not able to halt or reverse the degeneration. However, development of an efficient 
and safe treatment requires that the molecular characteristics and mode of action of the 
drug candidates, i.e. MANF and CDNF, are thoroughly studied and understood. In this 
work, Drosophila melanogaster was used as a model to study the MANF/CDNF protein 
family function within a multicellular organism in vivo. 
 
The specific aims of this study were: 
 
I Explore the functional conservation between Drosophila Manf and its 
human homologues 
 
II Characterize the structural and functional components of Drosophila Manf 
protein  
 
III Identify genetic interaction partners of Drosophila Manf 
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3 MATERIALS AND METHODS 
Materials and methods used in the individual studies (I, II and III) are presented in the 
original  articles.  In  this  chapter,  I  summarize  the  methods  I  have  applied  myself  in  the  
work presented in this thesis. These and the methods used by the other authors of studies I, 
II and III are listed in Table 1. 
 
Table 1. Methods used in this study. The methods numbered in “Chapter” column I have used myself in at 
least one of the articles indicated. U, unpublished data. 
Method Article Chapter 
Fly work      
Fly husbandry and strains I II III U 3.1 
Generation of transgenic flies I II   3.1, 3.2 
Rescue experiments I II III U 3.3 
Molecular methods      
Plasmid constructs I II   3.2 
RNA extraction  II III  3.4 
RT-PCR analysis  II    
Quantitative RT-PCR (qPCR)   III   
Northern blot analysis I     
Protein extraction I II III  3.5 
Western blot analysis I II III  3.5 
Immunohistochemistry I II III U 3.6 
Measurement of dopamine concentration I II    
Transmission electron microscopy I     
In vitro cell culture and transfection      
Schneider-2 cell culture I II    
Chinese hamster ovary (CHO) cell culture  II    
Injection of superior cervical ganglion (SCG) neurons  II    
Data acquisition and analysis      
Microscopes, imaging and image analysis I II III U 3.6 
Statistical analysis I II III U 3.7 
3.1 Fly husbandry, strains and transgenesis 
Flies were maintained at 25 ºC if not mentioned otherwise. The growing medium 
consisted of malt, agar, semolina and yeast. Propionic acid and methyl 4-hydroxybenzoate 
were used as antifungal and antimicrobial compounds, respectively. 
As a wild type, w– strain maintained in our laboratory was used. Mutations and 
balancer chromosomes essential for the work presented in this thesis are listed in Table 2. 
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In  the  work  presented  in  this  thesis,  DmManf mutant stands for DmManfD96 allele if not 
stated otherwise. The GAL4 lines used and their expression patterns are described in Table 
3. UAS-lines and the purpose they were used for are presented in Table 4. The UAS-lines 
generated in II are comprehensively described in the original article, and the main 
characteristics of these constructs are illustrated in Figure 9 in Results and discussion 
section. UAS-RNAi lines used in III are listed in the original manuscript. 
 
Table 2. Mutations and balancer chromosomes. Cy (Curly) results in dominant curly wing phenotype. 
BDSC, Bloomington Drosophila Stock Center. 
Mutation/ 
Balancer 
Description Source and citation 
DmManfD96 Null allele of DmManf I 
debclW105 Putative dominant negative allele of debcl (fly BAX 
homologue) 
BDSC; Sevrioukov et al. 
2007 
debclE26 Amorphic allele of debcl BDSC; Sevrioukov et al. 
2007 
TM6B P{Dfd-
EYFP}3 Sb Tb 
Third chromosome balancer with Tb and Sb markers (see 
Chapter 3.3) 
BDSC 
T(2;3)SM6a-
TM6B Tb 
Translocation balancer against second and third 
chromosomes with Cy and Tb markers 
BDSC 
sqh-EYFP-ER Ubiquitous ER-directed expression of EYFP used as an ER 
marker 
BDSC; LaJeunesse et al. 
2004 
 
Table 3. GAL4 lines with description of the expression patterns. Most of the GAL4 lines are expressed 
in the larval salivary glands (Brand and Perrimon 1993). BDSC, Bloomington Drosophila Stock Center; da, 
daughterless; GMR, Glass Multimer Reporter; repo, reversed polarity; salm, spalt major; tub, tubulin. 
GAL4 line Expression pattern Source and citation 
69B-GAL4 Central nervous system (CNS), epidermis, gut, imaginal 
discs, proventriculus, ring gland, salivary glands, trachea 
J. Mattila; Brand and 
Perrimon 1993 
C135-GAL4 Proventriculus, salivary glands L. Hrdlicka; Hrdlicka et al. 
2002 
da-GAL4 Ubiquitous excluding proventriculus BDSC; Wodarz et al. 1995 
GMR-GAL4 Eye disc BDSC; Freeman 1996 
MS1096-GAL4 Wing pouch, partially in CNS O. Shimmi; Capdevila and 
Guerrero, 1994 
Repo-GAL4 Glial cells excluding midline glia I. Salecker; Sepp and Auld 
1999 
salm-GAL4 Imaginal discs, ring gland, salivary gland, trachea BDSC; Hinz et al. 1994 
tub-GAL4 Ubiquitous BDSC, Lee and Luo 1999 
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Table 4. UAS lines and the purposes for which they were used in this study. BDSC, Bloomington 
Drosophila Stock Center, VDRC, Vienna Drosophila RNAi Center. 
UAS line Description Source 
UAS-DmManf Wild type allele of DmManf, transformant lines 133/L3 
and 135/L5 
I 
UAS-HsMANF Wild type allele of human MANF II 
UAS-HsCDNF Wild type allele of human CDNF II 
UAS-DmManf-RNAi RNAi construct against DmManf mRNA, transformant 
line 12835 
VDRC; Dietzl et al. 2007 
UAS-lacZ lacZ reporter; a dose control for UAS/GAL4 binary 
expression system 
J. Larsson; Brand and 
Perrimon 1993 
UAS-mCD8-GFP GFP reporter with membrane directing tag (murine 
CD8); a dose control for UAS/GAL4 binary 
expression system 
BDSC, Lee and Luo 
1999 
UAS-GFP.nls GFP reporter with nuclear localization sequence (nls) BDSC, Shiga et al. 1996 
UAS-Hsc70-3WT Wild type allele of Hsc70-3 (fly GRP78 homologue) BDSC, Elefant and 
Palter 1999 
UAS-Hsc70-3K97S Dominant negative allele of Hsc70-3 BDSC, Elefant and 
Palter 1999 
UAS-Hsc70-3D231S Dominant negative allele of Hsc70-3 BDSC, Elefant and 
Palter 1999 
UAS-PEK Wild type allele of PEK (fly PERK homologue) S.J. Marciniak; Malzer et 
al. 2010 
 
The constructs used to generate transgenic fly lines were cloned according to the 
descriptions in the original articles (I, II, see also Chapter 3.3). The injections to generate 
the transgenic lines were done by us (I) or Genetic Services, Inc. (II). Independent 
insertions were isolated and made homozygous, when possible. Insertion chromosome of 
each transformant line was analysed by in situ hybridization on larval giant polytene 
chromosomes (I) or by genetic crosses (II). 
3.2 Plasmid constructs 
A schematic design of the DmManf constructs is presented in Figure 5. The constructs 
were cloned according to standard molecular methods and the details are presented in the 
original articles (I, II). The mutations and tags to DmManf, HsMANF and HsCDNF 
cDNA (II) were introduced by inverse PCR mutagenesis using Phusion® Hot Start High-
Fidelity DNA polymerase (Finnzymes). pBlueScript SK was used as an intermediate 
vector. In human MANF and CDNF, honeybee mellitin was used as a secretion signal 
peptide. pUAST vector was used in the generation of transgenic lines (I, II), pMT vector 
in the expression studies on transfected Drosophila Schneider-2 cells (I, II) and pCR3.1 
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vector in transfection (CHO cells) or injection (SCG neurons) of the cultured mammalian 
cells (II). 
 
Figure 5. Schematic presentation of DmManf construct design. The number of amino acids in each part, 
secretion signal sequence (ss), N-terminal domain and C-terminal domain, are indicated. In tagged 
constructs, the V5-tag was inserted between ss and N-terminal domain. Start, start codon; ss, secretion signal 
sequence; Stop, stop codon; aa, amino acid. 
3.3 Rescue experiments 
The lethal phenotype of larvae homozygous for a loss of function allele of DmManf (I) 
was used in the rescue experiments in which a UAS-transgene was expressed by a GAL4 
line in homozygous DmManf mutant background (Figure 6). The rescue of larval lethality 
was evaluated by appearance of pupae and pupal lethality by presence of adults 
representing the lethal genotype. A third chromosome balancer with Tb (Tubby, short and 
rounded body phenotype) and Sb (Stubble, short and blunt-ended bristle phenotype) 
dominant markers was used and emerging of the rescued individuals was monitored by 
appearance of Tb+ pupae and Sb+ adults. Parents were allowed to lay eggs for 2–3 days. 
The quantification of the rescue efficiency was evaluated by counting the amount of 
rescued pupae from 5 or 15 vials 9–10 days after the beginning of egg laying (I, II). The 
amount of rescued pupae was normalized by dividing it by 0.33 (homozygous UAS lines) 
or 0.17 (heterozygous UAS lines) according to Mendelian inheritance. Emerged rescued 
adults were counted 10–17 days after the beginning of egg laying. The amount of emerged 
adults was divided by the number of Tb+ pupae. 
 
Figure 6. Schematic example of rescue crosses. 
The genotypes, pupal phenotypes (caused by Tb 
marker) and expected proportions (based on 
Mendelian inheritance) of progeny are presented 
in the diagram below the cross. Homyzygous 
DmManf mutants are lethal at early larval 
stageGrey box indicates the rescued genotype. 
For description of the genetic components, see 
Tables 2 and 3. 
3.4 RNA extraction and RT-PCR 
Total RNA was extracted from larvae or adults (II, III). In II, RNeasy Mini Kit (Qiagene) 
was used in RNA extraction and RQ1 RNase-Free DNase (Promega) in DNase treatment. 
In III, NucleoSpin® RNA II (Macherey-Nagel) was used to extract RNA with on-column 
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DNase treatment by rDNase included in the kit. RNA was further purified using 
NucleoSpin® RNA II and the concentration and quality of purified RNA were analysed 
by NanoDrop. 
M-MLV Reverse Transcriptase (Promega) was used to synthesize cDNA and GoTaq® 
Hot Start Polymerase in PCR reaction (II). PCR products were analysed on 1% agarose 
gel by electrophoresis. 
3.5 Protein extraction and Western blot analysis 
Protein extraction was made by homogenizing embryos (I, II), larvae (I, II, III) or adults 
(I) in lysis buffer supplemented with Complete proteinase inhibitor tablets (Roche). 
Cultured cell media was collected and stored, and the cells were lysed with lysis buffer. 
Buffers used are described in II. Western blotting was done according to the instructions 
provided by the manufacturer. The following rabbit polyclonal antibodies were used: anti-
DmManf (I, II, III; generated in I), anti-HsMANF (II; Lindholm et al. 2008), anti-
HsCDNF (I, II; Lindholm et al. 2007) and anti-V5 (II; Invitrogen). Anti-Twinfilin (I; 
Wahlström et al. 2001) or anti-Tubulin (II, III; Sigma) was used as a loading control. 
3.6 Immunohistochemistry, imaging and image analysis 
Larvae were dissected and fixed in 4% paraformaldehyde in PEM (100 mM PIPES 
pH 7.0, 2 mM EGTA, 1 mM MgSO4) for 30 min. Tissues were incubated with primary 
antibody at 4 ºC overnight and with secondary antibody at room temperature for 1 h. Anti-
DmManf (I) was used to detect DmManf protein expression and anti-pHis3 [phospho-
Histone H3 (Ser10), 06-570, Upstate] to identify mitotic cells (Hendzel et al. 1997). 
Tissues were mounted with VECTASHIELD® Mounting Medium with or without DAPI 
(Vector Laboratories) and imaged with TCS SP5 laser scanning microscope (Leica 
Microsystems) equipped with HCX PL APO 20x/0.7 Imm Corr or HCX APO 63x/1.30 
Corr CS 21 glycerol immersion objective. Imaris (Bitplane Inc.) and ImageJ (Abràmoff et 
al. 2004) softwares were used for image analysis. For the quantification of pHis3 positive 
cells, automatic “Spots” algorithm in Imaris 7.6.0 was used. 
3.7 Statistical analysis 
The means were compared by Student’s t-test and the null hypothesis was rejected at 
p<0.05. The statistical analysis was performed by using Microsoft® Excel Analysis 
ToolPak. The statistical significance of the survival of SCG neurons was analysed by one-
way ANOVA and post hoc Dunnett’s test (II). 
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4 RESULTS AND DISCUSSION 
4.1 DmManf is vital for normal Drosophila development (I) 
To understand the function of DmManf, its expression was examined during 
embryogenesis (I) and larval stage (Palgi 2012) by immunohistochemical and in situ 
hybridization  analyses.  Similar  to  mammalian  MANF,  DmManf  showed  relatively  wide  
expression pattern with preference for the secretory tissues. Studies using germline mosaic 
clones in vivo and transiently transfected Schneider-2 cells in vitro indicated that DmManf 
is a secreted protein (I). Later, a detailed intracellular analysis has revealed that DmManf 
is also partially localized to ER and mitochondria (Palgi et al. 2012; Palgi 2012). 
For further functional analysis, deletions to DmManf gene were generated by P-
element excision (I). A loss of function allele of DmManf gene, DmManfD96, was used in 
studies presented in this thesis. Flies homozygous for DmManfD96 allele (hereafter referred 
as DmManf mutant)  failed  to  complete  the  1st larval molt and died as early 2nd instar 
larvae. Heterozygous DmManf mutants showed no obvious phenotype. 
According to Northern blot analysis, DmManf mRNA was expressed throughout the 
development and in adult flies (I). Strong mRNA and protein expressions were detected in 
the early stages of embryogenesis indicating that DmManf was maternally deposited. The 
lethality of DmManf mutant larvae occurred after maternal DmManf load had worn out. In 
order to study the effects of the complete loss of DmManf, the maternal DmManf was 
abolished by germline mosaic technique. The loss of both zygotic and maternal DmManf 
lead to lethality during the final stage of embryogenesis and the embryos failed to hatch. 
In contrast to zygotic mutant larvae, the maternal and zygotic DmManf mutant embryos 
showed dramatic disorganization of the central and peripheral nervous systems. 
Additionally, the cuticle of these mutant embryos was severely defective. 
4.1.1 The loss of DmManf alters dopaminergic system (I, II) 
Mammalian MANF was originally identified as a survival-promoting factor for 
dopaminergic neurons (Petrova et al. 2003). In later studies, MANF and CDNF exhibited 
neuroprotective and neurorestorative effects on dopamine neurons in rodent models of PD 
(Lindholm et al. 2007; Voutilainen et al. 2009). In CNS, DmManf was expressed in glial 
cells excluding midline glia (I). The strongest expression was found in the cell body glia 
surrounding neurons immunoreactive for TH, the rate-limiting enzyme in dopamine 
synthesis commonly used as a marker for dopaminergic neurons (reviewed in Daubner et 
al. 2011). In DmManf mutants, a selective loss of dopaminergic neurites was detected just 
prior to lethality of the larvae. In the mutant embryos lacking both maternal and zygotic 
DmManf, the dopamine level was drastically lower in comparison to wild type. In these 
mutant embryos, the layering of the cuticle was severely disorganized probably due to the 
loss of dopamine. The cuticular layers are crosslinked by dopamine-derived quinones 
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during hardening of the cuticle (Wright et al. 1996; reviewed in Jane et al. 2005). The 
components used to build the cuticle are secreted by hypodermal cells. In zygotic DmManf 
mutant larvae, the expression of the hypoderm-specific transcript of pale, the Drosophila 
gene encoding for TH, was upregulated (Birman et al. 1994; Palgi et al. 2012). 
Accordingly, the dopamine levels were elevated in zygotic DmManf mutants probably 
reflecting the increased pale expression in the hypodermal cells (II). 
4.1.2 The loss of zygotic DmManf is rescued by ectopic DmManf expression (I, 
unpublished) 
To study whether the lethality observed in homozygous DmManf mutants was exclusively 
due to the loss of endogenous DmManf expression, transgenic fly lines with UAS-
construct encoding DmManf were generated (I; Figure 7). When UAS-DmManf was 
ubiquitously expressed by da-GAL4 or tub-GAL4 driver in homozygous DmManf mutant 
background, the lethality of DmManf mutants was rescued to adulthood. The rescued 
adults were fertile and showed no obvious phenotype. This demonstrated that DmManf 
mutant lethality was solely due to the loss of endogenous DmManf. 
To explore in which tissues DmManf expression is required for development, UAS-
DmManf construct was expressed in homozygous DmManf mutant background in a tissue-
specific manner. DmManf was found to be a secreted protein and function as an 
extracellular trophic factor (I). Thus, expression in exactly same cells in which 
endogenous DmManf is expressed might not be necessary but – instead – achieved via 
secreted DmManf pool from neighbouring cells. Proventriculus-specific expression of 
UAS-DmManf by C135-GAL4 was not able to rescue DmManf mutant lethality 
suggesting that a single, concerted source of DmManf was not enough for viability (I). To 
summarize the rescue experiments with various GAL4 drivers, the ectopic DmManf 
expression either in or in close proximity to hypodermal cells was sufficient to rescue the 
larval lethality of homozygous DmManf mutants (data not shown). These data indicate 
that the essential quantity of DmManf for viability can be achieved as a secreted protein. 
This also suggested that the primary reason for the lethality of DmManf mutants was 
disturbances in the development of cuticle (I and data not shown). In contrast, glial-
specific expression of UAS-DmManf by repo-GAL4 failed to rescue DmManf mutants 
indicating that glial-derived DmManf is not sufficient for proper development of the 
cuticle. However, the role of DmManf in cuticle formation should be addressed in more 
detailed studies at the molecular level. 
One of the GAL4 lines with such an expression pattern in which the ectopic DmManf 
expression was sufficient to complement for the loss of endogenous DmManf was 69B-
GAL4 (I). The expression of transgenic DmManf by 69B-GAL4 alone was sufficient to 
maintain the viability and fertility of DmManf mutants.  Actually,  a  fly  line  with  such  a  
genotype (DmManfD96 69B-GAL4/DmManfD96 UAS-DmManfL3 on the 3rd chromosome) 
has been successfully maintained in our laboratory for several years. The absence of wild 
type DmManf allele in this stock was verified by PCR (data not shown). The 69B-GAL4 
driver has been commonly employed as an epidermal driver. However, further analysis 
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revealed that GAL4 is expressed almost ubiquitously excluding fat body and gastric caeca. 
Additionally, a patterned expression in imaginal discs, cuticle and CNS was detected. 
Thus, it is termed as a semi-ubiquitous driver in this thesis. 
 
Figure 7. Rescue of DmManf mutant lethality by ectopic expression of DmManf, HsMANF and 
HsCDNF. Schematic presentation of DmManf, HsMANF and HsCDNF transgenes as well as recombinant 
construct with N-terminal domain of HsMANF and C-terminal domain of HsCDNF (HsMANF-HsCDNF, 
red corresponds to the HsCDNF sequence inserted into HsMANF transgene and green to a fragment of C-
terminal domain of HsMANF). Results of rescue experiments with ubiquitous (da) and semi-ubiquitous 
(69B) GAL4 drivers are presented. Markings used: ++, full rescue; (+), subtle (only few pupae observed) 
rescue; --, no rescue of DmMant mutant lethality. In constructs with human MANF and CDNF, honeybee 
mellitin (20 aa) was used as a secretion signal peptide. aa, amino acid. Modified from II. 
4.1.3 HsMANF and HsCDNF are able to substitute for the endogenous DmManf 
(I, II) 
To study the functional conservation, transgenic fly lines carrying an UAS-construct 
encoding either human MANF or CDNF were generated (I, II, Figure 7). Similar to UAS-
DmManf construct, the ubiquitous expression of either human MANF or CDNF were able 
to rescue DmManf mutant lethality to adulthood (II). The emerged adults were fertile and 
showed no obvious phenotype. These results confirm that MANF is functionally 
conserved during evolution and both of the human paralogues, HsMANF and HsCDNF, 
are able to complement for the lack of endogenous fly protein. 
To  test  whether  restricted  expression  of  human  transgenes  affects  their  ability  to  
complement for the loss of endogenous DmManf expression, 69B-GAL4 was used in the 
rescue experiments (II). This driver was selected because ectopic DmManf in its non-
ubiquitous expression pattern is able to rescue DmManf mutant lethality (I, see Chapter 
4.1.2). Expression of HsMANF by 69B-GAL4 rescued DmManf mutant lethality similar 
to  DmManf  transgene  (II).  However,  when  HsCDNF  was  used,  the  amount  of  rescued  
pupae was drastically decreased. To dissect the differences between the human 
paralogues,  a  recombinant  HsMANF-HsCDNF  construct  was  built.  In  this  construct,  C-
terminal domain of HsMANF (amino acid residues 105-158) was replaced with that of 
HsCDNF (amino acid residues 101-164). This recombinant construct rescued DmManf 
mutant lethality when ubiquitously expressed but failed to do so with 69B-GAL4 driver. 
This result indicated that the functional differences between the two human paralogues 
reside in the C-terminal domain. To confirm this hypothesis, a construct with N-terminal 
domain  of  HsCDNF  and  C-terminal  domain  of  HsMANF  (HsCDNF-HsMANF)  was  
generated. Unfortunately, no transformant lines of this construct were obtained and the 
hypothesis could not be tested. 
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4.1.4 Knockdown of DmManf is efficient and specific in vivo (III) 
In order to study tissue-specific requirements for DmManf, a transgenic UAS-DmManf-
RNAi line was used to knock down DmManf expression (III). First, the efficiency and 
specificity of the knockdown by UAS-DmManf-RNAi construct was verified. When 
DmManf was ubiquitously knocked down with tub-GAL4, qPCR and Western blot 
analyses showed that both mRNA and protein levels of DmManf were reduced. 
Ubiquitous knockdown of DmManf with tub-GAL4 and da-GAL4 drivers resulted in 
lethality at larval stage with few escapers (approximately 5%) which died during pupal 
stage. To further confirm the specificity, heterozygous DmManf mutant background was 
used to reduce the endogenous DmManf mRNA expression. When DmManf was 
ubiquitously knocked down with tub-GAL4 in heterozygous DmManf mutant background, 
no pupae or wandering 3rd instar larvae were detected closely resembling the zygotic 
DmManf mutant phenotype. The larval lethality caused by ubiquitous knockdown of 
DmManf was rescued to adulthood by simultaneous overexpression of UAS-DmManf, 
UAS-HsMANF or UAS-HsCDNF. These data indicate that UAS-DmManf-RNAi 
specifically and efficiently knocked down endogenous DmManf expression. 
4.1.5 DmManf is involved in wing disc cell proliferation (III) 
DmManf is ubiquitously expressed in the 3rd instar larval wing disc (II). The knockdown 
of DmManf by GAL4 drivers with expression in the wing, e.g. MS1096-GAL4, resulted in 
altered adult wing phenotype. In MS1096-GAL4 driver line GAL4 is expressed in the 
wing pouch area and also partially in CNS (Capdevila and Guerrero 1994; Neumann and 
Cohen 1996; our unpublished observations). Additionally, the GAL4 insertion is located 
on the X chromosome. In Drosophila males, the X chromosomal dosage compensation is 
achieved by hyperactivation of the X-linked genes (reviewed in Laverty et al. 2010; 
Georgiev et al. 2011). Thus, the GAL4 expression in MS1096-GAL4 driver is expected to 
be stronger in the males. Silencing of DmManf by MS1096-GAL4 resulted in a bent-up 
wing phenotype and this phenotype was stronger in males consistent with the X-
chromosomal GAL4 insertion (III, Figure 8A). When heterozygous DmManf mutant 
background was used, phenotype was stronger, even leading to a complete loss of the 
wing in males. This also provided additional evidence for the specificity of UAS-
DmManf-RNAi construct. 
To confirm the specificity of DmManf knockdown by MS1096-GAL4, UAS-DmManf-
RNAi line was co-expressed together with overexpression constructs UAS-DmManf, 
UAS-HsMANF and UAS-HsCDNF. The wing phenotype in both females and males was 
reverted  back  to  wild  type  (III,  Figure  8A).  In  wild  type  background,  no  phenotype  was  
detected when these constructs were expressed by MS1096-GAL4 (III, data not shown). 
The silencing of human MANF has been shown to stimulate cell proliferation in vitro 
(Apostolou et al. 2008). In contrast, the loss of MANF suppressed and overexpression 
enhanced proliferation of mouse pancreatic b-cells in vivo (Lindahl et al. 2014). To 
investigate whether DmManf is involved in regulation of cell proliferation in Drosophila, 
the larval wing discs in which DmManf was knocked down by MS1096-GAL4 were 
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studied (III). Proliferating cells were identified by a mitotic marker pHis3 (Hendzel et al. 
1997) within the GFP-expressing wing disc area of 3rd instar male larvae. The number of 
pHis3 positive cells was significantly increased when DmManf was knocked down in 
heterozygous DmManf mutant background in comparison to heterozygous DmManf 
mutant alone (Figure 8B). However, this result is controversial to the phenotype observed 
in adult males in which the wing blade was small or even completely lost. In a developing 
wing disc, few apoptotic cells are found and they can be detected e.g. by acridine orange 
staining (Milán et al. 1997). However, the larval wing discs from males in which DmManf 
was knocked down with MS1096-GAL4 showed no difference in acridine orange staining 
in comparison to wild type (data not shown). Thus, the molecular mechanisms resulting in 
the drastic wing phenotype subsequent to the loss of DmManf remain unsolved. 
 
Figure 8. Knockdown of DmManf in the wing results in altered adult wing phenotype. A) The observed 
wing phenotype in adult males, see text for details. B) Quantification of pHis positive cells within GFP-
expressing wing disc area of 3rd instar male larvae. UAS-mCD8-GFP was used to detect the GAL4 
expressing region. *, P < 0.05, Student’s t-test. Modified from III. 
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4.2 Studies on the structural and functional features of MANF/CDNF 
in vivo (II) 
Several features identified in the amino acid sequence (Petrova et al. 2003; Lindholm et al. 
2007; Apostolou et al. 2008; Lindholm et al. 2008) and three-dimensional structure 
(Parkash et al. 2009; Hellman et al. 2011) are predicted to be involved in the function and 
interaction of MANF/CDNF proteins. To dissect the structural and functional components 
of the MANF/CDNF family, a series of mutations in DmManf were designed (II, Figure 
9). Mutated DmManf cDNAs were cloned into pUAST constructs and transgenic flies 
were generated. The rescue model (see Figure 6 and Chapter 3.3) was used to test whether 
the transgenes could complement for the loss of endogenous DmManf despite the 
mutations. First, transgenes were expressed ubiquitously by da-GAL4 driver and their 
ability to rescue DmManf mutant lethality was evaluated. However, if the mutation affects 
intracellular trafficking or extracellular distribution of DmManf protein, abundant 
expression of the mutated protein by da-GAL4 might hide these effects. Thus, 69B-GAL4 
was used to express transgenes in homozygous DmManf mutant background in a non-
ubiquitous manner (see Chapter 4.1.2). Western blot analysis revealed that the overall 
GAL4 expression level in 69B-GAL4 was mildly decreased when compared to da-GAL4 
(II). In comparison to the endogenous DmManf expression, the ectopic expression of 
DmManf by 69B-GAL4 produced clearly higher DmManf protein level. Apparently, the 
possible differences in the rescue experiments with da-GAL4 and 69B-GAL4 drivers do 
not result from deficient DmManf expression level but from incomplete expression pattern 
of 69B-GAL4. In comparison to ubiquitous da-GAL4, 69B-GAL4 lacks expression in 
muscles, gastric caeca and fat body. Additionally, the expression in CNS and epidermis is 
decreased in comparison to da-GAL4. To address the issues with expression pattern and 
tissue-specific expression level, targeted mutagenesis to endogenous DmManf gene should 
be performed to express the mutated gene under endogenous DmManf promoter (reviewed 
in Venkel and Bellen 2005). However, this approach was beyond the scope of current 
work. 
To  study  the  effects  of  mutations  on  secretion  of  DmManf,  Schneider-2  cells  were  
transfected with V5-tagged DmManf constructs in pMT vector. The V5-DmManf protein 
expressed by transfected plasmids was analysed in cell lysates and media with an antibody 
against V5-tag by Western blotting (II). To avoid disturbing the secretion signal peptide or 
the putative interaction with KDEL-R, V5-tag was inserted after the secretion signal 
sequence and prior to the N-terminal domain of mature DmManf protein (Figure 5). 
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Figure 9. Mutations in DmManf transgenes and their ability to rescue DmManf mutant lethality. A 
schematic presentation of designed DmManf constructs and results of the rescue experiments with 
ubiquitous da-GAL4 and semi-ubiquitous 69B-GAL4 drivers. Red bars indicate point mutations, broken line 
a deletion (for detailed explanations, see Chapters 4.2.1–4.2.5). Colouring is according to amino acid 
sequence alignment presented in Figure 1. Markings used: ++, full rescue; (+), subtle (only few pupae 
observed) rescue; --, no rescue of DmMant mutant lethality. Below, an example of a combination of N- and 
C-terminal domain constructs is presented (see Chapter 4.2.5). Modified from II. 
4.2.1 Positively charged surface amino acids affect DmManf functionality (II) 
The N-terminal domain of MANF (N-MANF) shows high similarity to SAPLIPs, a 
protein family with lipid-interacting functions (Parkash et al. 2009). N-MANF has two 
patches of positively charged surface amino acids that are predicted to interact with the 
negatively charged membrane lipids (Parkash et al. 2009). The first patch consists of 
amino acid residues R15, K80, K84, K86, and K87 and the second patch of R44, K46, 
R49 and K96 (numbering according to HsMANF amino acid sequence without secretion 
signal). Two mutated DmManf constructs were created in which selected amino acid 
residues from each of the patches were replaced with neutral alanine (II, Figure 9). In the 
first construct, DmManf-NMG1 (N-terminal mutant group 1), mutations K79A, K83A and 
K86A were created corresponding to amino acid residues K80, K84 and K87 in HsMANF. 
In the second construct, DmManf-NMG2, mutations K43A, K45A and R95A were 
introduced corresponding to amino acid residues R44, K46 and K96 in HsMANF. When 
ubiquitously expressed, both of these constructs were able to rescue the DmManf mutant 
lethality and thus replace the endogenous DmManf (II, Figure 9). 
When semi-ubiquitous 69B-GAL4 driver was used, DmManf-NMG2 construct was 
able to rescue DmManf mutant lethality (II). However, DmManf-NMG1 failed to rescue 
mutant lethality indicating that the positive surface potential in the corresponding patch is 
crucial for proper DmManf functionality. Either mutation group (NMG1 or NMG2) did 
not notably affect the levels of secreted or cellular amounts of V5-tagged DmManf in 
comparison to wild type construct (II). Thus, the surface potential affects other molecular 
characteristics of DmManf than secretion. In further studies, the intracellular trafficking 
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and putative lipid interaction of both constructs should be studied in detail. Additionally, a 
construct in which all nine positively charged surface amino acid residues are neutralised, 
should be studied. 
4.2.2 ER retention is necessary when the availability of DmManf is restricted (II) 
Similar  to  mammalian  MANF,  DmManf  has  been  shown  to  localize  to  ER  (Palgi  et  al.  
2012). A putative ER retention signal sequence, RSEL, is located at the very C-terminal 
end of DmManf. To test whether this sequence is responsible for localizing DmManf to 
the ER, a DmManf construct with deleted RSEL sequence was created (DmManf-DRSEL) 
(II, Figure 9). UAS-DmManf (wild type construct) and UAS-DmManf-DRSEL were 
expressed by da-GAL4 driver and DmManf co-localization with an ER marker (transgenic 
sqh-EYFP-ER construct) was studied in homozygous DmManf mutant background in 
order to avoid detecting the endogenous DmManf. The ER localization of DmManf-
DRSEL was significantly decreased in comparison to wild type DmManf in vivo (II, 
Figure 10). In vitro studies  showed  that  the  deletion  of  ER  retention  signal  clearly  
increased the level of secreted V5-DmManf-DRSEL in the medium and decreased the 
amount of V5-DmManf-DRSEL in cell lysates in comparison to wild type construct. This 
demonstrated that the suggested role of RSEL sequence as an ER retention signal is 
functional and conserved (II). 
 
Figure 10. Deletion of ER retention signal 
affects intracellular localization of DmManf. 
UAS-DmManf and UAS-DmManf-DRSEL were 
expressed by ubiquitous da-GAL4 driver in 
homozygous DmManf mutant background. In 3rd 
instar larval Garland cells, the expression from 
UAS constructs was detected by immunostaining 
with anti-DmManf. The co-localization of 
DmManf (red) and EYFP (green) is shown as 
yellow. Reprinted from II. 
 
In rescue experiments, the ubiquitous expression of DmManf-DRSEL construct by da-
GAL4 resulted in full rescue of the larval and pupal lethality of homozygous DmManf 
mutants (II, Figure 9). However, when semi-ubiquitous 69B-GAL4 was used, the ability 
of DmManf-DRSEL to rescue DmManf mutant larval lethality was notably decreased. 
This indicated that the ER-retained DmManf has a crucial role for fly viability when the 
availability of DmManf is restricted. 
The ER retention of mammalian MANF has been shown to be mediated by its C-
terminal RTDL sequence (Glembotski et al. 2012; Oh-Hashi et al. 2012; Henderson et al. 
2013). To study the conserved role of ER-retained MANF, HsMANF transgene with a 
deletion  of  the  ER  retention  signal  (HsMANF-DRTDL)  was  used  (II).  Similar  to  
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corresponding DmManf construct (DmManf-DRSEL), HsMANF-DRTDL was able to 
rescue DmManf mutant lethality when ubiquitous da-GAL4 driver was used but failed to 
do so when expressed by semi-ubiquitous 69B-GAL4 (II). This demonstrated that the 
functional importance of the ER-retained MANF is conserved. It also opens an intriguing 
opportunity to study the functional difference between the C-terminal domain of human 
MANF  and  CDNF  (see  Chapter  4.1.3).  In  future  studies,  the  ER  retention  signal  of  
HsCDNF,  KTEL,  could  be  replaced  with  the  unique  ER  retention  signal  of  HsMANF,  
RTDL. The rescue experiments with restricted expression pattern of 69B-GAL4 driver 
could give a hint whether the different ER retention signals contribute for the functional 
difference between the human paralogues. Additionally, the replacement of the ER 
retention signal of DmManf and HsMANF with the canonical KDEL sequence could 
further enlighten the role of ER retained MANF protein in this in vivo model. 
4.2.3 Disrupting the C-terminal CXXC motif by C129S mutation (II) 
The C-terminal domain of MANF has a CXXC motif characteristic for thiol-disulphide 
oxidoreductases. A disulphide bridge between the cysteines in CXXC motif stabilizes the 
folding  of  C-terminal  domain  of  MANF  and  CDNF  (Parkash  et  al.  2009;  Hoseki  et  al.  
2010; Hellman et al. 2011). To study the importance of this CXXC motif in DmManf, one 
of the cysteine residues was mutated by point mutation C129S (II, Figure 9). Interestingly, 
ubiquitous expression of DmManf-C129S failed to rescue DmManf mutant lethality.  The 
transfected Schneider-2 cells showed similar levels of cellular and secreted V5-DmManf-
C129S in comparison to wild type V5-DmManf suggesting that interrupting the C-
terminal CXXC motif does not affect the secretion of DmManf. These data demonstrated 
that the intact CXXC motif has a crucial role in DmManf function in vivo but affects other 
cellular functions than secretion. The effects of C129S mutation are further discussed in 
Chapter 4.3.1. 
4.2.4 Entering the secretory pathway via ER is crucial for DmManf functionality (II) 
Both mammalian and Drosophila MANF  are  secreted  proteins  and  their  role  as  
extracellular trophic factors have been demonstrated in vivo (I; Lindholm et al. 2008; 
Voutilainen et al. 2009). To study the importance of signal sequence-directed entrance of 
DmManf to the secretory pathway via ER, a DmManf construct with a deletion of the N-
terminal secretion signal (ss) sequence was created (DmManf-Dss) (II, Figure 9). 
Interestingly, ubiquitous expression of this construct failed to rescue DmManf mutant 
lethality. DmManf-Dss or V5-DmManf-Dss was not detected in the medium of transfected 
CHO or Schneider-2 cells, respectively, indicating that the deletion of the secretion signal 
peptide actually abolished the secretion of DmManf. The Western blot analysis from 3rd 
instar larval lysates demonstrated that ubiquitously expressed DmManf-Dss, even when 
UAS/GAL4 expression system was enhanced by doubling both UAS- and GAL4 
insertions, showed clearly defective expression level in vivo. In transfected Schneider-2 
cells, the expression level of V5-DmManf-Dss was also lower in comparison to wild type 
RESULTS AND DISCUSSION  
 
 
 
 
 
46
V5-DmManf. This suggests that either the translation of DmManf-Dss in cytosol is 
defected or the cytosolic DmManf protein is degraded. The RT-PCR analysis revealed that 
the mRNA was expressed from UAS-DmManf-Dss transgene in vivo when ubiquitous da-
GAL4 driver was used. DmManf-Dss mRNA expression level did not differ from the 
mRNA expressed by the wild type construct supporting the hypothesis that the expression 
defect occurs post-transcriptionally. 
The molecular events affecting the expression level of DmManf-Dss protein are 
intriguing. MANF and CDNF are folded proteins and, putatively, the loss of ER-mediated 
folding of DmManf might lead to its ubiquitination and degradation via proteasome 
system. In future studies, the putative ubiquitination of cytosolic DmManf should be 
addressed. Additionally, the loss of secretion signal in DmManf-Dss has two 
consequences: it does not enter the ER and it is not secreted. While the loss of ER retained 
DmManf (DmManf-DRSEL, see Chapter 4.2.2) affected functionality only when its 
expression was restricted, it would be important to address whether the loss of secreted or 
ER-retained DmManf results in the deficient functionality. In order to reduce the secretion 
of  DmManf,  a  construct  in  which  the  ER  retention  signal  RSEL  is  replaced  with  the  
canonical KDEL sequence – and expected to result in higher affinity to KDEL-R and 
decreased secretion – could reveal whether secreted DmManf has a crucial role during 
development. 
4.2.5 Both N- and C-terminal domains as an intact full-length protein are needed for 
functional DmManf protein (II) 
Human MANF and CDNF consist of two domains, N-terminal and C-terminal (Parkash et 
al. 2009). Amino acid sequence of MANF is evolutionarily conserved and because the 
spacing between the eight cysteine residues is also conserved, DmManf is predicted to be 
structurally very similar to human MANF (I). To explore whether either N- or C-terminal 
domain alone includes the functional characteristics of DmManf important for fly 
viability, constructs of independent N- and C-terminal domains, with and without 
secretion signal sequence, were generated (II, Figure 9). Each of these transgenes was 
expressed individually by ubiquitous da-GAL4 driver in homozygous DmManf mutant 
background but none of them could complement for the lack of endogenous DmManf. 
Additionally, none of these constructs were able to rescue the wing phenotype observed in 
flies in which DmManf was knocked down by MS1096-GAL4 (data not shown, see 
Chapter 4.1.5). This indicates that both domains of DmManf have important functions 
during development. 
Simultaneous expression of N- and C-terminal domain constructs could retain the 
functional properties of DmManf essential for viability. Thus, combinations of N- and C-
terminal domain construct, with or without secretion signal sequence (see an example in 
Figure 9) were expressed by ubiquitous da-GAL4 driver in homozygous DmManf mutant 
background (II). However, co-expression of N- and C-terminal domain constructs, in any 
of the combinations, failed to rescue DmManf mutant lethality. These data indicate that in 
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addition  to  the  requirement  of  both  N-  and  C-terminal  domains  for  the  DmManf  
functionality, they also need to be expressed as an intact full-length protein. 
Western  blot  analysis  from  larval  lysates  revealed  that  N-  and  C-terminal  domain  
constructs with a secretion signal peptide (DmManf-N and DmManf-C) were abundantly 
expressed at the protein level. In contrast, the protein expressions produced by N- and C-
terminal domain constructs without the secretion signal peptide (DmManf-N-Dss and 
DmManf-C-Dss) were under the detection limit (II). Similar to DmManf-Dss construct, the 
mRNA expression of these constructs was not affected (see Chapter 4.2.4). Taken 
together, these data suggest that the ER-directed translation of DmManf is necessary for 
producing a stable DmManf protein. 
Although the data presented above strongly indicates that the N- and C-terminal 
domains need to be expressed as an intact full-length protein, the absolute requirement 
was not proven in this study. The peptide produced by C-terminal domain construct might 
be either degraded or misdirected. Based on the expression studies with the constructs 
encoding for independent domains, the C-terminal domain without the secretion signal 
sequence (DmManf-C-Dss) was most likely degraded even when co-expressed with the N-
terminal domain. Furthermore, the artificial DmManf C-terminal domain with the 
secretion signal peptide (DmManf-C) has both secretion signal (directing the translated 
peptide to ER) and ER retention signal (retaining the protein in ER). This might lead to 
incorrect intracellular localization for DmManf-C and result in its impaired function. 
The importance of N-terminal domain also remains uncertain. While secretion signal 
sequence directs the translation of DmManf-N to the ER, it then continues to the trans-
Golgi network and is secreted instead of retained to the ER due to the lack of ER retention 
signal. However, if DmManf is cleaved in the ER after its translation, this would be the 
outcome of endogenous expression as well. In Western blot analysis of larval lysates in 
which wild type DmManf was ubiquitously overexpressed, a faint band corresponding to 
the size of C-terminal domain was detected (II). This might result from a cleavage of 
DmManf protein, but such has never been found to occur endogenously. It is more 
probable that the appearance of a smaller protein band results from degradation of excess 
DmManf protein in the ER. However, no experiments were performed during this study to 
explore whether endogenous DmManf protein is cleaved into separate N- and C-terminal 
domains after its translation in the ER. 
To further test whether both N- and C-terminal domains of DmManf, as an intact full-
length protein, are necessary for fly viability in vivo, the N- and C-terminal domain 
constructs with connecting linkers should be generated and studied in the rescue model. 
This would reveal whether the loss of physical connection or other implications mentioned 
above are responsible for the inability of individual domain constructs to rescue DmManf 
mutant lethality. Furthermore, a DmManf-N construct with the DmManf ER retention 
signal (RSEL) added to the C-terminus would reveal whether retaining the DmManf-N in 
the ER would provide the important function of DmManf. 
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4.3 Effects of DmManf overexpression (III, unpublished) 
Previously, overexpression of DmManf was reported not to cause evident phenotypes in 
adult flies or embryonic nervous system (Palgi et al. 2012). Accordingly, the ubiquitous 
overexpression of DmManf by da-GAL4 or tub-GAL4 did not show any obvious 
phenotype or affect the larval or pupal viability quantified in current study (III). Similarly, 
overexpression of DmManf with either wing-specific MS1096-GAL4 or semi-ubiquitous 
69B-GAL4 driver did not cause any obvious phenotype (III). 
The alterations designed in the DmManf protein (II, Figure 9) could have dominant 
negative effects when expressed in wild type background. Additionally, they could 
interfere with the endogenous DmManf expression. The ubiquitous expression by da-
GAL4 of mutated DmManf constructs without the secretion signal sequence (DmManf-
Dss, DmManf-N-Dss and DmManf-C-Dss) did not affect the overall viability (data not 
shown). This indicates that cytoplasmic DmManf, either as a full-length protein or as an 
independent N- or C-terminal domain is not harmful for cells. However, because the 
protein expression of these constructs was defected (II), the lack of damaging effects 
might be merely due to the low expression levels. 
Except for the DmManf-C129S construct (see Chapter 4.3.1 below), ubiquitous 
overexpression of the mutated DmManf constructs with the secretion signal sequence, 
DmManf-DRSEL, DmManf-NMG1, DmManf-NMG2, DmManf-N and DmManf-C did 
not affect the viability or show any obvious phenotype under normal conditions (data not 
shown). This indicates that none of the modifications listed above exhibit negative effects 
on fly viability.  
Despite the normal phenotype of flies in which wild type DmManf is overexpressed 
with 69B-GAL4, a previous microarray analysis revealed altered expression of genes 
involved in various functions and biological processes in these flies (Palgi et al. 2012). 
Expression of genes annotated to function in regulation of cell cycle and related processes 
as well as cell death were upregulated. Evaluation of downregulated genes in response to 
DmManf overexpression indicated that several ER-related processes were deteriorated. 
Under normal conditions, these processes are probably in balance and do not affect the 
overall viability of DmManf-overexpressing flies. In future studies, flies overexpressing 
DmManf could be challenged with various stress conditions, e.g. ER  stress  or  the  fly  
model of PD.  
4.3.1 Overexpression of DmManf-C129S impairs normal development (unpublished) 
In contrast to any other DmManf constructs tested, normal fly development was disturbed 
by ectopic expression of the transgene carrying C-terminal cysteine mutation, DmManf-
C129S. Overexpression with ubiquitous tub-GAL4 (Table 5) and da-GAL4 (data not 
shown) led to lethality before pupal stage. The rescue studies suggested that DmManf-
C129S failed to complement for the loss of endogenous DmManf (II, Chapter 4.2.3). In 
fact, the overexpression studies indicated that C129S mutation does not only compromise 
the functionality of DmManf protein but also causes damaging effects. Additionally, the 
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overexpression of DmManf-C129S with wing driver MS1096-GAL4 resulted in defected 
adult wing similar to DmManf knockdown flies (Figure 11). These data indicate that 
DmManf-C129S represents either a dominant negative or a gain-of-function allele of 
DmManf. Co-expression of transgenic wild type DmManf and DmManf-C129S with 
ubiquitous tub-GAL4 did not rescue the lethality caused by DmManf-C129S expression 
(Table 5) suggesting that increasing the expression level of wild type DmManf does not 
alter the harmful effects of DmManf-C129S expression. Accordingly, the wing phenotype 
observed in flies overexpressing DmManf-C129S with wing-driver MS1096-GAL4 was 
not either rescued or worsened by simultaneous overexpression of transgenic wild type 
DmManf (Figure 11). 
The similarity between the wing phenotype in DmManf knockdown and DmManf-
C129S expressing flies suggests that DmManf-C129S actually impairs the function of 
wild type DmManf. Additionally, ubiquitous overexpression of DmManf-C129S resulting 
in lethality prior to the pupal stage remotely resembles the DmManf mutant phenotype. 
However, these phenotypic analyses were too coarse and more sophisticated readout for 
the loss of DmManf function should be found to address this hypothesis. 
The mutated DmManf-C129S protein contains an unpaired cysteine residue (C132) 
which prevents folding of the C-terminal domain. Recently, a Drosophila model for 
conditional expression of an unfolded protein (human proinsulin with mutation Ins2C96Y) 
was reported (Park et al. 2014, see Chapter 1.4.3.2). In 3–5 days old adult males, the 
expression of Ins2C96Y by eye-driver GMR-GAL4 resulted in retinal degeneration 
indicated by uneven surface of the compound eye.  It  was also shown that ER stress was 
induced by ectopic expression of Ins2C96Y. In order to study whether the disturbed C-
terminal CXXC motif in DmManf-C129S and the presence of unpaired cysteine residue 
(C132) has similar impact on eye development, GMR-GAL4 driver was used to express 
DmManf-C129S in the wild type background. However, no signs of retinal degeneration 
were detected and the eyes of this genotype showed no phenotype in 5 days old adult flies 
(Figure 11). Although the time point was same than used in the previous study (Park et al. 
2014), it does not exclude the possibility of age-dependent degeneration that was not 
assessed in this work. As a control for effective expression by GMR-GAL4, 
overexpression constructs of PEK (UAS-PEK) and a dominant negative allele of Hsc70-3 
(UAS-Hsc70-3D231S) were used. Overexpression of either of these constructs has been 
found to cause ER stress (Elefant and Palter 1999; Malzer et al. 2010). The overexpression 
of PEK showed similar degenerated small eye phenotype to previously reported data 
(Malzer et al. 2010) and the overexpression of Hsc70-3D231S resulted in severe retinal 
degeneration phenotype (Figure 11B). Based on these results, the presence of unpaired 
cysteine (C132) in the C-terminal domain of DmManf does not induce – at least severe – 
UPR in the eye. This is further supported by the co-expression studies of DmManf-C129S 
and wild type form of Hsc70-3 (UAS-Hsc70-3WT). Hypothetically, the elevated amount of 
Hsc70-3 should increase the binding of unfolded DmManf-C129S and relieve its negative 
effects. However, the pupal lethality of DmManf-C129S overexpression by ubiquitous 
tub-GAL4 driver was not rescued by simultaneous overexpression of Hsc70-3 (Table 5). 
Thus, the implications of DmManf-C129S at developmental, cellular and molecular level 
remain unsolved and should be thoroughly studied. 
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Table 5. Overexpression of DmManf, DmManf-C129S and Hsc70-3WT by tub-GAL4. Tb+ and Tb–, 
number of observed pupae of indicated phenotype. Adults, observed percentage of emerged adults out of Tb+ 
pupae. For each genotype, pupae and adults from six vials were counted. 
Constructs overexpressed Tb+ Tb– Adults 
None (wild type) 489 423 100% 
UAS-DmManfL5 444 359 93% 
UAS-Hsc70-3WT 409 369 100% 
UAS-DmManf-C129SL4 0 613 – 
UAS-DmManfL5 + UAS-DmManf-C129SL4 0 538 – 
UAS-Hsc70-3WT + UAS-DmManf-C129SL4 0 572 – 
 
Figure 11. Effects of ectopic DmManf-C129S mutant expression on Drosophila wing (A) and eye (B). 
A) Simultaneous overexpression of wild type DmManf (UAS-DmManf) did not affect the wing phenotype 
caused by DmManf-C129S overexpression. In comparison, the phenotype in DmManf-knockdown by UAS-
RNAi construct was rescued by overexpression of wild type DmManf. B) In 5 days old adults, ectopic 
DmManf-C129S in the eye showed no retinal degeneration. UAS-PEK was driven by GMR-GAL4 at 18 ºC 
as its overexpression resulted in lethality at 25 ºC, consistent with the original study (Malzer et al. 2010). 
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SXXC motif has been shown to be involved in enzymatic redox functions in 
prokaryotes (Fomenko and Gladyshev 2002). SXXC motif has also been identified in a 
mammalian ER-resident protein disulphide isomerase-like in the testis (PDILT) (van Lith 
et al. 2005). Although lacking the CXXC motif, PDILT was able to interact with 
oxidoreductase Ero1a, and is involved in intermolecular disulphide-dependent complex 
formation. Additionally, a SXXC motif has been identified to reside next to the cysteine-
rich vitelline membrane domain of a Drosophila protein VM26Ab (Vitelline membrane 
26Ab, also known as sV23) (Wu et al. 2010). This protein is involved in the composition 
of oocyte vitelline membrane and in formation of intermolecular disulphide linked 
complexes. Thus, it is possible that the C129S mutation in DmManf, forming a CXXS 
motif, could gain disulphide-dependent functions and hamper disulphidation pathway. 
This would also explain why simultaneous overexpression of wild type DmManf did not 
rescue the phenotypes caused by expressing the DmManf-C129S mutant. Functions for 
DmManf related to disulphide bond formation are disputed by the finding that both N- and 
C-terminal domain CXXC motifs in mammalian MANF lack PDI activity (Hartley et al. 
2013). However, this does not completely exclude the possibility that PDI-like activities 
would exist in the CXXC motifs of DmManf. 
In conclusion, the C129S mutation could have two consequences. First, it results in an 
unpaired cysteine residue (C132) and prevents folding of the C-terminal domain which 
might have a toxic effect, e.g. by causing constant ER stress and activating UPR. Second, 
the loss of CXXC motif could alter DmManf function and gain unknown detrimental 
effects. To explore whether the unpaired cysteine residue (C132) is responsible for the 
negative effects of DmManf-C129S expression, a construct in which both of the cysteine 
residues within the CXXC motif are mutated should be studied. This construct could give 
further answers whether the harmful effects are due to the deficient functionality of 
DmManf  protein  or  the  unpaired  cysteine  residue.  Additional  characterization  of  the  C-
terminal CXXC motif in DmManf would be of great importance for understanding the 
function and conservation of MANF/CDNF family. 
4.4 Identification of genetic interaction partners of DmManf (III) 
Despite the studies during the last decade, very little is known on how MANF/CDNF 
impact biological processes and which proteins they interact with. To address this issue, 
genetic interacting partners of DmManf were studied by utilizing the transgenic UAS-
RNAi method from the genetic toolbox of Drosophila (III). The knockdown of DmManf 
in the wing resulted in a drastic wing phenotype and strongly indicated a role for DmManf 
in wing development (see Chapter 4.1.5). Thus, the UAS-RNAi lines of target genes were 
driven in the wing disc and the adult wings were monitored for phenotypes. Both 
candidate and unbiased screen approaches were used. For the candidate genes, two sets of 
UAS-RNAi lines were tested: a) a selection of genes encoding for proteins known to have 
a function related to ER or ER stress response (hereafter referred as “ER genes”) and b) 
genes encoding for transcription factors that are predicted to bind DmManf promoter 
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region. Additionally, a partial unbiased screen of genome-wide UAS-RNAi libraries was 
performed. In both approaches MS1096-GAL4 was used as a wing driver (see Chapter 
4.1.5 for more detailed description of the expression pattern) and 69B-GAL4 as a semi-
ubiquitous driver (see Chapter 4.1.2) to knock down the target gene expression in wild 
type background. The phenotypes were then compared to knockdown of target gene in 
heterozygous DmManf mutant (to reduce DmManf expression level) or DmManf-
overexpressing (to increase amount of DmManf) backgrounds. These backgrounds alone 
did not show any obvious phenotypes. The genes showing altered phenotype in either 
heterozygous DmManf mutant or DmManf-overexpressing backgrounds in comparison to 
wild type background were considered as genetic interacting partners of DmManf. A 
schematic presentation of the screen approach is presented in Figure 12A. 
4.4.1 Overall evaluation of the approach to identify genetic interactions 
Although the screen approach used in this study enabled identification of genetic 
interacting partners of DmManf, it was not further evaluated whether the observed 
association represented a direct, physical interaction or did it demonstrate a biochemical 
interaction. The interactors might act in the same signalling pathway but the detected 
genetic interaction might only result from an additive effect on general cellular function, 
e.g. cell proliferation or apoptosis. Further studies are necessary to explore on what level 
the identified genetic interactions are executed. 
For several genes assessed in the unbiased screen, knockdown with wing-driver 
MS1096-GAL4 resulted in more severe, but similar, phenotypes in both heterozygous 
DmManf mutant and DmManf-overexpressing backgrounds (III). This is surprising 
because reducing and increasing the DmManf level are expected to have opposite effects. 
MS1096-GAL4 driver has a patterned expression in the developing wing disc. When 
simultaneous DmManf overexpression is used, both knockdown of the target gene and 
overexpression of DmManf occurs in the GAL4-expressing cells while in the surrounding 
cells, endogenous expression levels are expected to remain (illustrated in Figure 12B). 
This creates a concentration gradient of DmManf expression. The overexpression level is 
not affected by the knockdown of target gene as it is not regulated by endogenous 
DmManf promoter. In the case of heterozygous DmManf mutant background, the target 
gene is silenced within GAL4 expression pattern while all cells have heterozygous 
DmManf expression level. If the knockdown of a target gene alters DmManf expression 
via the endogenous DmManf promoter, there might actually be either lower 
(downregulation) or higher (upregulation) DmManf levels within the GAL4 expression 
pattern in comparison to surrounding cells. This in turn could create a gradient of 
DmManf expression resembling the overexpression situation. In other words, the two 
genetically different DmManf backgrounds studied, heterozygous mutant and 
overexpression, were not comparable to each other. However, the actual cause for these 
observations was not studied further and, thus, remained speculative. 
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4.4.2 DmManf interaction with ER genes 
4.4.2.1 Interaction between GRP78 and MANF is conserved in Drosophila (III, 
unpublished) 
Mammalian MANF has been shown to interact directly with the major ER chaperone 
GRP78 (Glembotski et al. 2012). In the screen of candidate genes with ER-related 
function, a genetic interaction between the Drosophila gene encoding the homologue to 
GRP78, Hsc70-3, and DmManf was  found  (III).  The  knockdown  of  Hsc70-3 with wing 
driver MS1096-GAL4 in the wild type background resulted in severely bent-up wing 
phenotype in adult females. When simultaneous DmManf overexpression was used, the 
wing phenotype was stronger resulting in almost complete loss of the wing. 
In embryos in which Hsc70-3 was knocked down by semi-ubiquitous 69B-GAL4 
driver, the mRNA level of DmManf was  elevated  in  comparison  to  wild  type  (data  not  
shown). Additionally, both total and spliced Xbp1 mRNA levels were increased (data not 
shown) suggesting a transcriptional activation of Xbp1. These data also imply that ER 
stress response is induced and are further discussed in Chapter 4.4.2.5. 
The knockdown of Hsc70-3 with ubiquitous tub-GAL4 driver was lethal prior to pupal 
stage (III). Additionally, overexpression of dominant negative alleles of Hsc70-3, UAS-
Hsc70-3D231S and UAS-Hsc70-3K97S was  used  (Elefant  and  Palter  1999).  Similar  to  the  
knockdown of Hsc70-3 by UAS-RNAi construct, the ubiquitous overexpression of UAS-
Hsc70-3D231S and UAS-Hsc70-3K97S resulted in lethality prior to pupal stage (data not 
shown). Simultaneous overexpression of DmManf did not rescue any of these lethal 
phenotypes demonstrating that DmManf cannot complement for the functional loss of 
major ER chaperone Hsc70-3 (III, unpublished). 
In order to test whether Hsc70-3 could complement for the loss of endogenous 
DmManf, an overexpression construct for wild type allele of Hsc70-3 (UAS-Hsc70-3WT) 
was used (III). This construct was expressed ubiquitously by da-GAL4 driver in 
homozygous DmManf mutant background similar to the rescue experiments described 
above (see Chapter 3.3). However, overexpression of Hsc70-3 did not rescue DmManf 
mutant lethality suggesting that DmManf and Hsc70-3 have distinct functions during 
development. The simultaneous overexpression of both DmManf and Hsc70-3 in wild 
type background did not affect overall viability or show any obvious phenotypes in 
emerged flies. This demonstrated that a concurrent, abundant expression of both DmManf 
and Hsc70-3 does not have deleterious effects. 
Although mammalian MANF has been shown to bind unfolded proteins in vitro 
(Hartley et al. 2013), the increased DmManf protein expression could not complement for 
the loss of major ER chaperone Hsc70-3 in vivo (III). In contrast, overexpression of 
DmManf actually disturbed even further the wing phenotype caused by decreased levels of 
Hsc70-3. This suggests that the presence of large amounts of DmManf in the ER acquires 
Hsc70-3, perhaps by regulating the folding of DmManf or maintaining an appropriate 
DmManf protein level inside the ER. Alternatively, the loss of interaction between 
mammalian MANF and GRP78 was associated with increased secretion of MANF 
(Glembotski et al. 2012). The knockdown of Hsc70-3 could lead to increased secretion of 
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DmManf and, similar to rescue experiment with DmManf-DRSEL (see Chapter 4.2.2), 
could compromise viability. On the other hand, the excess amounts of DmManf could 
bind the residual Hsc70-3 and retain it from its important functions. In any case, the 
interaction between Drosophila Manf and Hsc70-3 should definitely be studied in depth. 
4.4.2.2 DmManf interacts with PEK, a transducer of UPR (III) 
Expression of MANF has been shown to be induced in response to ER stress (Lee et  al.  
2003; Girardot et al. 2004; Mizobuchi et al. 2007; Apostolou et al. 2008; Lindholm et al. 
2008; Nundlall et al. 2010). Studies on mammalian systems indicate that regulation of 
MANF expression upon ER stress is mediated by transcription factors ATF6 and XBP1s 
(Lee et al. 2003; Mizobuchi et al. 2007; Belmont et al. 2008; Wang et al. 2011; Oh-Hashi 
et al. 2013). Of the genes encoding for the UPR transducer proteins (Ire1, PEK and Atf6), 
a genetic interaction with DmManf was identified for PEK in this study (III). The 
knockdown of Ire1 or Atf6 with MS1096-GAL4 or 69B-GAL4 drivers did not cause any 
obvious phenotype in wild type, heterozygous DmManf mutant or DmManf-
overexpressing backgrounds. However, the approach used here does not exclude an 
interaction between DmManf and Ire1 or Atf6. 
With all tested drivers, MS1096-GAL4, 69B-GAL4 and tub-GAL4, the knockdown of 
PEK showed more severe phenotype when DmManf was overexpressed in comparison to 
wild type background. Heterozygous DmManf mutant background did not alter the 
phenotypes caused by knocking down PEK.  The  qPCR  analysis  revealed  that  DmManf 
mRNA level in 2nd instar larvae was increased when PEK was knocked down with 
ubiquitous tub-GAL4 in wild type background. Interestingly, these larvae showed no 
altered mRNA levels of either total or spliced Xbp1 (data not shown). This is in contrast 
with the previous study demonstrating that the loss of endogenous PEK resulted in the 
unconventional splicing of Xbp1 (Malzer et al. 2010). This suggested that the knockdown 
of PEK with tub-GAL4 in wild type background alone was not efficient enough to induce 
UPR. 
In a previous study, the loss of zygotic DmManf was shown to upregulate PEK mRNA 
level  and  to  increase  the  phosphorylation  of  eIF2α,  a  target  of  PEK (Pomar  et  al.  2003;  
Palgi et al. 2012). Putatively, overexpression of DmManf could either downregulate PEK 
expression or disturb the proper activation of PEK. Thus, it would impair the inhibition of 
overall protein synthesis. However, this hypothesized direct interaction between DmManf 
and PEK has not been explored, yet. 
4.4.2.3 Interaction between DmManf and Xbp1 (III) 
A genetic interaction was detected between DmManf and Xbp1, the gene encoding for the 
transcription factor activated by Ire1-mediated unconventional splicing which has a central 
role in the activation and regulation of UPR. Knockdown of Xbp1 with MS1096-GAL4 
and 69B-GAL4 showed no phenotype in wild type background. When simultaneous 
overexpression of DmManf was used, knockdown of Xbp1 resulted in severe phenotypes 
(III). The UAS-Xbp1-RNAi line used in this study targets both the unspliced and the 
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unconventionally spliced mRNA of Xbp1 and  the  efficient  knockdown  of  Xbp1 was 
verified by qPCR (data not shown). 
Knockdown of Xbp1 with ubiquitous tub-GAL4 did not alter DmManf mRNA levels 
analysed by qPCR in 2nd instar larvae (III). During normal development, ER stress is 
detected especially in secretory cells and silencing of XBP1 has been found to disturb the 
maintenance of this developmental ER stress (Iwawaki et al. 2004; Souid et al. 2007; Hess 
et al. 2011; Sone et al. 2013; Ryoo et al. 2013). Previous studies of mammalian MANF in 
vitro indicate that XBP1s mediates the UPR-induced upregulation of MANF (Lee et al. 
2003; Oh-Hashi et al. 2013). As knockdown of Xbp1 did not enable the upregulation of 
DmManf in response to presumed ER stress (III), altogether these data suggest that XBP1 
is essential for regulation of MANF expression. 
The genetic interaction between Xbp1 and DmManf indicates that Ire1 could also – at 
least genetically – interact with DmManf. Further studies would reveal whether this 
putative interaction actually exists. 
4.4.2.4 Overexpression of DmManf induces Xbp1 expression (unpublished) 
To  study  the  effect  of  DmManf  overexpression  on  UPR,  UAS-DmManf  was  driven  by  
ubiquitous tub-GAL4 and the Xbp1 mRNA  levels  were  analysed  by  qPCR  in  2nd instar 
larvae. Intriguingly, the overexpression of DmManf not only induced the mRNA 
expression of Xbp1 but also increased the level of the spliced from, Xbp1s. Consequent of 
the increased level of total Xbp1 the ratio of spliced/total Xbp1 was not affected. This 
strongly indicated that DmManf overexpression caused ER stress and activated the 
transcriptional upregulation of Xbp1. Nonetheless, expression of secretory proteins in 
general causes ER stress (reviewed in Hetz and Glimcher 2008) – thus the observed 
activation of Xbp1 expression might not specifically result from DmManf overexpression. 
4.4.2.5 Summary and implications of DmManf interaction with ER genes (III) 
A genetic interaction was detected between DmManf and  ER  genes  Hsc70-3, PEK and 
Xbp1. Additionally, similar interaction was found between DmManf and sip3 (septin 
interacting protein 3, Drosophila homologue of synoviolin/HRD1), a protein involved in 
ERAD (III). Non-ubiquitous knockdown of each of these genes (excluding Hsc70-3) had 
only minor implications on overall fly viability or morphology in wild type background. 
However, simultaneous overexpression of DmManf (which alone does not cause any 
obvious phenotype or affect fly viability, see Chapter 4.3) together with knockdown of 
these genes resulted in drastic phenotypes. Reducing the DmManf expression level by 
heterozygous DmManf mutant background did not affect the knockdown of ER genes. 
It is puzzling why DmManf overexpression has negative effect on the knockdown of 
genes with ER-related functions. MANF expression has been shown to be induced upon 
ER stress and it has been hypothesized to have a protective role against ER stress 
(Apostolou et al. 2008; Airavaara et al. 2009; Voutilainen et al. 2009). However, the 
overexpression levels obtained by UAS/GAL4 system are probably a lot higher than the 
upregulated levels of mammalian MANF detected in vitro studies in which ER stress 
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upregulated MANF expression approximately 2-fold (Glembotski et al. 2012; Hartley et 
al. 2013). Although not analysed in detail, overexpression of DmManf by ubiquitous da-
GAL4 and semi-ubiquitous 69B-GAL4 drivers resulted in notably higher DmManf protein 
levels in comparison to endogenous expression level (II). The consequences of DmManf 
overexpression could mimic the effects of increased overall protein expression on ER 
homeostasis rather than indicate specific ER-related functions of DmManf. However, this 
issue was not studied in detail during this work. It is still possible that at certain 
concentrations DmManf could have a protective role and only excess amounts have 
negative effects. The suggested protective role of MANF against ER stress should be 
studied with more delicate methods to regulate the DmManf expression levels, e.g. by 
increasing the copy number of DmManf genomic regions by transgenic constructs. 
A previous microarray analysis revealed that the transcription of several UPR-related 
genes, including PEK and sip3, was downregulated in DmManf-overexpressing larvae 
(Palgi et al. 2012). The decreased sip3 expression was also verified by qPCR analysis 
(Palgi et al. 2012). Knockdown by UAS-RNAi construct results in silencing of the target 
gene and the efficiency differs between different UAS-RNAi lines. If overexpression of 
DmManf downregulates the expression of important UPR components, there would be 
less mRNA to be degraded. Thus, the efficiency of knockdown would be improved and 
enhance the silencing of target gene. This would give a simple explanation why DmManf 
overexpression has negative effects on the knockdown of ER-related genes. In future, the 
mRNA levels of UPR-related genes should be analysed in DmManf-overexpressing flies 
to examine this hypothesis. 
Knocking down certain genes involved in ER-related functions might disturb UPR 
process. For example, the loss of transcription factor Xbp1s could interrupt the 
transcriptional regulation of UPR-induced gene expression, and decrease in Hsc70-3 
expression levels could severely compromise the protein folding capacity in the ER. 
Indeed, the knockdown of Hsc70-3 resulted in increased levels of both total and spliced 
Xbp1 mRNAs indicating induction of UPR. Under normal conditions in wild type 
background, cells still manage to overcome these alterations. However, when DmManf is 
simultaneously overexpressed, cellular homeostasis is disrupted and cells are probably 
directed  towards  apoptosis.  The  translation  of  DmManf  is  targeted  to  the  ER  by  N-
terminal  secretion  signal  peptide  and  it  could  simply  act  as  a  substrate  for  UPR in  non-
specific manner. In this scenario, overexpression of DmManf would cause a massive 
protein load in the ER. Under normal conditions, the ER homeostasis is retained by 
increasing the folding capacity through UPR. The putative degradation of overexpressed 
DmManf supports this hypothesis (II, see also Chapter 4.2.5). When an important piece of 
normal ER function or UPR is missing, e.g. Hsc70-3 or PEK, cells fail  to overcome ER 
stress and the cell death pathways are activated. This is supported by the increased Xbp1 
mRNA levels in response to overexpression of DmManf. However, whether 
overexpression of DmManf is involved in ER stress-related apoptosis is yet unsolved. 
Although the approaches used in this work provide evidence for the contribution of 
DmManf in Drosophila UPR, it needs to be more comprehensively studied in the future. 
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4.4.3 Screening the candidate genes encoding for TFs (unpublished) 
Drosophila Interactions Database (DroID, www.droidb.org) lists computationally and 
experimentally determined interactions between transcription factors (TFs) and genes that 
they may regulate based on REDFly database (Halfon et al. 2008) and modENCODE 
project (Roy et al. 2010). For DmManf, 20 candidate TFs are listed (Data version 
2013_07). By using the UAS-RNAi approach, Centrosomal protein 190kD (Cp190) and 
Chromator (Chro) were identified to genetically interact with DmManf (Figure 13). The 
knockdown of Cp190 by 69B-GAL4 showed a wrinkled wing phenotype with incomplete 
penetrance (Figure 13). In contrast, adult males with wrinkled wing phenotype were not 
found when DmManf was overexpressed. Thus, overexpression of DmManf rescued the 
loss of Cp190 indicating that Cp190 could act as a positive regulator of DmManf 
expression. The knockdown of Chro by MS1096-GAL4 showed a mildly wrinkled wing 
phenotype in wild type background. In heterozygous DmManf mutant background, 
knockdown of Chro by MS1096-GAL4 led to strongly wrinkled wings (data not shown). 
These data indicate that Cp190 and Chro might act in transcriptional regulation of 
DmManf expression. However, more detailed analyses, e.g. by luciferase assay with 
DmManf promoter or by qPCR analysis of DmManf mRNA levels in Cp190 and Chro 
knockdown flies, should be performed to confirm these interactions. 
4.4.4 The genetic interaction of DmManf and genes with mitochondrial function (III) 
The screen of approximately 2800 Drosophila genes resulted in identification of 21 genes 
as interacting partners of DmManf (III, Figure 12A). Four of these genes were 
unannotated. A Gene Ontology (GO) term analysis of the remaining 17 genes strongly 
indicated that DmManf interacts with genes that function in mitochondria. The most 
enriched GO terms were ubiquinone related processes (2 genes), mitochondrial cellular 
compartment (6 genes) and cellular metabolic process (13 genes). Additionally, three 
genes with unknown cellular compartment had human homologues annotated to 
mitochondria. Mitochondria are often referred as the power plants of cells and they have 
an important role in oxidative phosphorylation and calcium signalling. Previously, 
DmManf has been shown to partially co-localize with a mitochondrial marker in salivary 
glands (Palgi 2012). However, no co-localization of mammalian MANF and 
mitochondrial marker was detected in SH-SY5Y in vitro (Henderson et al. 2013). This 
might indicate distinct roles for MANF in different cell types or during evolution. 
4.4.4.1 DmManf and ubiquinone synthesis pathway (III) 
Ubiquinone (Q), also known as coenzyme Q, is an electron carrier involved in the electron 
transport chain in mitochondria (reviewed in Hatefi 1985; Aguilaniu et al. 2005; Crane 
2007). Q also participates in other cellular processes, e.g. protects phospholipids and 
lipoproteins against lipid peroxidation, and is found in membranes of different organelles 
in all cells. In Drosophila, only six genes are annotated to be involved in the 
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Figure 13. Screening the candidate TFs predicted to bind DmManf promoter region. Results from 
UAS-RNAi fly experiments (this study) and previous microarray analysis (MAA, Palgi et al. 2012) are 
shown. UAS-RNAi lines were crossed to MS1096-GAL4 and 69B-GAL4 drivers in wild type, heterozygous 
DmManf mutant and DmManf-overexpressing backgrounds. Observed phenotypes of knockdown flies in 
heterozygous DmManf mutant background (het vs. wt) or DmManf-overexpressing background (OE vs. wt) 
were compared to phenotypes of knockdown flies in wild type background. In MAA results, mutant larvae 
stands for zygotic DmManf mutant larvae, OE larvae for 69B-GAL4>UAS-DmManfL3 larvae, and mutant 
embryos for maternal and zygotic DmManf mutant embryos. 
Q synthesis pathway or closely related processes (Figure 14). The partial but unbiased 
screen for DmManf interacting partners contained two of these genes, encoding for 
enzymes COQ7 (coenzyme Q7 homologue) and CG9249 [homologue of coenzyme Q3 
(COQ3)]. Both of these genes were identified as genetic interacting partners of DmManf 
(III). With all three drivers used, MS1096-GAL4, 69B-GAL4 and tub-GAL4, knockdown 
of COQ7 showed more severe phenotype in DmManf-overexpressing background 
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compared to wild type. In wild type background, knockdown of COQ3/CG9249 with 
ubiquitous tub-GAL4 and semi-ubiquitous 69B-GAL4 drivers resulted in lethality. With 
MS1096-GAL4, knockdown of COQ3/CG9249 showed a bent-up wing phenotype. This 
phenotype was more severe leading to wrinkled wings when either heterozygous DmManf 
mutant or DmManf-overexpressing backgrounds were used (see Chapter 4.4.1). 
Another four genes annotated to be involved in the Q synthesis were analysed in 
further studies (III). Knockdown of COQ2/CG9613 by ubiquitous tub-GAL4 resulted in 
decreased pupal viability when DmManf was simultaneously overexpressed in comparison 
to wild type background. Taken together, three genes from the Q synthesis pathway were 
identified to genetically interact with DmManf (Figure 14). The SAPLIP-like N-terminal 
domain of MANF and CDNF might interact with lipids (Parkash et al. 2009) and the 
protective role of Q against lipid peroxidation could give further answers for the link 
between DmManf and ubiquinone synthesis pathway. 
In  addition  to  Q synthesis,  other  indications  of  DmManf  involvement  in  the  electron  
transport chain were found in the unbiased screen. Two genes identified as genetic 
interacting partners of DmManf, encoding for ND75 (NADH:ubiquinone reductase 75 kD 
subunit precursor) and lethal(2)37Bb, have human homologues that have been found to be 
mutated in patients diagnosed with mitochondrial complex I deficiency (Online Mendelian 
Inheritance in Man, phenotype number 252010). The data obtained from the unbiased 
screen (III) together with the previously reported subcellular localisation studies (Palgi 
2012) suggests that DmManf functions in mitochondria. These findings deserve a further 
evaluation in future studies. 
 
Figure 14. Simplified schematic presentation 
of ubiquinone synthesis pathway. Three 
components were found to interact with DmManf 
(marked in grey). COQ3 is involved in earlier 
steps but also acts in the final stage of ubiquinone 
synthesis. Adapted from III, drawn according to 
Kyoto Encyclopedia of Genes and Genomes. 
4.4.4.2 Role of ubiquinone in mitochondrial dysfunction and human disease 
Dysfunctional mitochondrial biogenesis and metabolism are related to variety of human 
disorders  (reviewed  in  Scharfe  et  al.  1999;  Balaban  et  al.  2001).  The  loss  of  Q,  a  state  
referred as Q deficiency, is associated mainly with neuronal and muscular defects (Quinzii 
et al. 2008). One of the causes for Q deficiency is the loss of COQ7, 
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demethoxyubiquinone (DMQ) hydroxylase which also leads to impaired ATP synthesis 
and accumulation of Q precursor, DMQ (Marbois and Clarke 1996; Jonassen et al. 1998; 
Jonassen et al. 2001; Stenmark et al. 2001; Takahashi et al. 2012). Mitochondrial function 
has also been suggested to play a major role in pathology of PD (reviewed in Schon and 
Przedborski 2011) and the studies on neuroprotective properties of Q in PD models have 
been promising (reviewed in Jin et al. 2013). Q deficiency leads to destabilization of 
mitochondrial complex I (García-Corzo et al. 2013). Mutations in the subunits of complex 
I have been linked to familial forms of PD (reviewed in Schon and Przedborski 2011). 
MPTP, paraquat and rotenone, toxins used to induce PD-like symptoms, are also known to 
interfere with complex I function (Langston et al. 1983; Betarbet et al. 2000).  
4.4.5 Interaction between DmManf and Drosophila homologue of Ku70 (III) 
C-terminal domain of MANF is structurally similar to SAP-domain of Ku70 (Hellman et 
al. 2011). In the unbiased genetic screen, an interaction between DmManf and Irbp 
(Inverted repeat-binding protein), the Drosophila gene encoding for the homologue of 
Ku70 was identified (III). In wild type background, knockdown of Irbp by wing-driver 
MS1096-GAL4 resulted in wrinkled wing phenotype. In heterozygous DmManf mutant 
background, adult flies showed clearly milder wing phenotype than in wild type 
background. In a previous microarray analysis, heterozygous DmManf mutant embryos 
(with abolished maternal DmManf) showed upregulation of Irbp mRNA (Palgi et al. 
2012). In homozygous mutant embryos lacking both zygotic and maternal DmManf, Irbp 
mRNA expression was even more upregulated (Palgi et al. 2012) indicating that the 
decrease of DmManf levels results in transcriptional upregulation of Irbp. The microarray 
results are in accordance with the knockdown phenotypes – the partial rescue of wing 
phenotype observed in DmManf heterozygous mutant background could be due to 
elevated Irbp expression. Taken together, these data suggest that decreased DmManf 
expression induces Irbp expression (III; Palgi et al. 2012). 
4.4.5.1 Intracellular neuroprotectivity of C-MANF is conserved in Drosophila (II) 
C-MANF shows a remarkable structural similarity to SAP-domain of Ku70 via which 
Ku70 binds BAX and inhibits BAX-mediated apoptosis (Sawada et al. 2003). In addition, 
mammalian MANF and C-MANF were found to be cytoprotective against BAX-mediated 
cell death in cultured mouse SCG neurons (Hellman et al. 2011). To test the functional 
conservation, plasmids encoding for full-length DmManf, with its endogenous secretion 
signal, and C-terminal domain of DmManf without secretion signal (DmManf-C-Dss) 
were microinjected into mouse SCG neurons (II). Both DmManf and DmManf-C-Dss, the 
corresponding constructs for the human counterparts used in the original study (Hellman 
et al. 2011), significantly inhibited the etoposide-induced cell death. This indicated that 
while  human  MANF  and  CDNF  are  able  to  function  in  Drosophila in vivo, DmManf 
possesses the cytoprotective functions of MANF/CDNF protein family conserved during 
evolution. 
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4.4.5.2 Partial redundancy of Irbp and DmManf functions? (III) 
Ubiquitous knockdown of Irbp by tub-GAL4 in wild type background resulted in lethality 
at pupal stage and no adults emerged. When DmManf was simultaneously overexpressed, 
this lethality was partially rescued to adulthood. The eclosed adults showed no obvious 
phenotype. Similar to mammalian Ku70, both mammalian and Drosophila MANF  were  
capable of supporting mammalian SCG neurons from induced cell death in vitro (II; 
Hellman et al. 2011). These data together indicate that DmManf and Irbp could have 
partially redundant functions. However, this hypothesis remains to be verified in future 
studies. 
4.4.5.3 Loss of the pro-apoptotic member of Drosophila BCL-2 family does not rescue 
DmManf mutant lethality 
The structural and functional similarity between C-MANF and SAP-domain of Ku70 (II; 
Hellman et al. 2011) together with the genetic interaction between DmManf and Irbp (III) 
suggest that MANF could interact with BAX. Hypothetically, the loss of endogenous 
DmManf could lead to decreased inhibition of Debcl, the BAX homologue in Drosophila, 
and subsequent increased cell death. This could account for the molecular cause of 
DmManf mutant lethality. In order to test this hypothesis, two alleles of debcl, amorphic 
debclE26 and a putative dominant negative debclW105,  as  well  as  UAS-debcl-RNAi line 
were used to abolish debcl expression (III). Alleles of debcl were combined with DmManf 
mutant and UAS-debcl-RNAi was driven by ubiquitous da-GAL4 driver in homozygous 
DmManf mutant background. However, the larval lethality of homozygous DmManf 
mutant was not rescued by abolishing the Debcl expression. This indicates that during 
development, the molecular functions of DmManf other than related to Debcl are more 
important for fly viability. Accordingly, the number of apoptotic cells in CNS of DmManf 
mutant embryos was not increased compared to wild type (I). Putatively, the increased 
expression  of  Irbp  upon loss  of  DmManf  could  take  over  the  Debcl-related  functions  of  
DmManf. In addition, the role of BCL-2 family members in Drosophila apoptosis is less 
important in comparison to mammals (Sevrioukov et al. 2007; Galindo et al. 2009). 
Another indirect link between DmManf and Debcl was identified in the unbiased 
genetic screen. One of the genes identified as interacting partners of DmManf was Tom20 
(Translocase of outer membrane 20) that encodes a receptor component of translocase of 
outer membrane (TOM) complex (III). TOM is responsible for directing proteins encoded 
by nuclear genes into the mitochondria. In Drosophila, the TOM complex is built by 
seven subunits (Hwa et al. 2004). Another component of TOM, Maggie/TOM22 is 
involved in the localization of Debcl to mitochondria and modulates the permeabilization 
of the mitochondrial outer membrane during apoptosis (Colin et al. 2009). The genetic 
interaction identified between DmManf and Tom20 might be a secondary effect of the 
proposed interaction between DmManf and Debcl, or vice versa. In future studies it would 
be necessary to study whether DmManf co-localizes with TOM proteins and if either Irbp 
or Debcl are involved in this putative interaction. 
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5 CONCLUSIONS 
In this study, Drosophila melanogaster was used as a model to explore the function and 
genetic interactions of the MANF/CDNF protein family in vivo. These proteins have 
neurotrophic properties and there is increasing evidence suggesting that they are involved 
in the ER stress response and, more generally, in cellular homeostasis beyond that of 
neuronal function. Here, the main findings of this work are summarized. 
DmManf is essential during Drosophila development. The endogenous expression of 
DmManf can be replaced by ectopic expression of either DmManf or its human 
orthologues, HsMANF and HsCDNF. The functional conservation between fly and human 
proteins opened a window for studies of the MANF/CDNF protein family in the 
Drosophila in vivo model. In addition to the conserved role of human orthologues in 
Drosophila in vivo, the Drosophila Manf protein possesses the cytoprotective properties 
of mammalian MANF in vitro. This indicates that the functional properties of the 
MANF/CDNF family proteins have evolved early during evolution of metazoans and 
further justifies the use of the powerful Drosophila model for analysing the MANF/CDNF 
protein family. While the in vitro research has revealed important aspects of the molecular 
mechanism of MANF/CDNF proteins, in vivo analyses are essential to study their function 
and interaction pathways in multicellular environment. The recently established MANF 
knockout mouse model will surely benefit in untangling several important issues in the 
future. However, the diverse genetic tools of the Drosophila model will substantially 
enhance this research. 
The ability of the transgenic DmManf construct to rescue DmManf mutant lethality 
was applied to explore how designed mutations affect DmManf functionality. The ER 
conserved retention mediated by a C-terminal RSEL sequence of DmManf was discovered 
to be important for DmManf functionality. Similarly, neutralizing the positive charge of 
the surface amino acid residues K79, K83 and K86 of DmManf had a negative impact on 
fly viability when availability of DmManf was restricted. Deletion of the secretion signal 
leads to instability of DmManf at the protein level and this mutated DmManf cannot 
complement  the  loss  of  endogenous  DmManf.  Furthermore,  both  N-  and  C-terminal  
domains as an intact full-length protein are necessary for proper function of DmManf. 
This characterization of the structural and functional determinants revealed several 
important aspects of DmManf function and forms an essential basis for further studies. 
The  modification  of  the  C-terminal  CXXC  motif  of  DmManf  by  a  C129S  point  
mutation does not only disturb the functionality of DmManf but also results in deleterious 
consequences during development in wild type background. These presumably dominant 
negative impacts are not alleviated by overexpression of wild type DmManf. For example, 
the presence of unpaired cysteine residue (C132) may cause UPR. However, the eye-
specific expression of DmManf-C129S does not cause the retinal degeneration phenotype 
observed in previous studies on Drosophila UPR models. Furthermore, overexpression of 
the Drosophila homologue of the major ER chaperone GRP78 does not protect from the 
harmful influence of DmManf-C129S expression. The molecular basis behind the effects 
of DmManf-C129S on cellular homeostasis remains to be studied in the future. 
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An interaction between mammalian MANF and GRP78 has previously been shown in 
vitro.  In  this  work,  a  genetic  interaction  between  the  fly  homologue  of  GRP78  and  
DmManf was demonstrated in vivo. Furthermore, DmManf was found to interact with 
other  genes  that  encode  proteins  known to  be  involved  in  ER function  and  UPR.  These  
results offer further evidence for MANF functioning in ER-related processes and support 
the studies of MANF/CDNF protein in Drosophila UPR.  Additionally,  the  genetic  
interaction studies presented in this thesis revealed novel functions for DmManf related to 
ubiquinone synthesis and mitochondria. 
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